## **Consolidated Annual Report and Accounts**
For the year ended 31 December 2025
0
Registered Charity No. 213280 Scottish Registered Charity No. SC041594
**Royal College of Obstetricians and Gynaecologists**
## **Contents**
## **For the year to 31 December 2025**
## **Contents**
|About The Royal College of Obstetricians and Gynaecologists|2|
|---|---|
|Welcome from our Chair|3|
|Message from our Chief Executive Officer|4|
|Message from our President|5|
|Progress against our goals|6|
|Financial review|15|
|Governance|21|
|Independent auditor’s report|31|
|Consolidated statement of financial activities|36|
|Balance sheets|37|
|Consolidated statement of cashflows|38|
|Notes to the financial statements|39|
© 2026 Royal College of Obstetricians and Gynaecologists First published 2026
All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.
Published by the Royal College of Obstetricians and Gynaecologists Royal College of Obstetricians and Gynaecologists 10-18 Union Street
London SE1 1SZ
UK
Registered Charity No. 213280
Scottish Registered Charity No. SC041594
**Royal College of Obstetricians and Gynaecologists**
## **About the Royal College of Obstetricians and Gynaecologists**
## **For the year ended to 31 December 2025**
## **About the Royal College of Obstetricians and Gynaecologists**
## **The Royal College of Obstetricians and Gynaecologists (RCOG) works to improve women’s healthcare across the world. The RCOG is committed to developing the accessibility and quality of education, training and assessments for doctors wishing to specialise in obstetrics and gynaecology (O&G).**
Founded in 1929, the RCOG has been transforming women’s healthcare for 96 years. The College is recognised nationally and overseas as a leader in women’s healthcare, enabling the organisation to build incredible international partnerships. With this network and expertise, the RCOG is working to advance the science and practice of O&G.
Today, the College has 19,000 members worldwide. These healthcare professionals can access support throughout each stage of their career. The College encourages all O&G members to pursue lifelong learning and development, offering cutting-edge training programmes and courses. **Find out more at www.rcog.org.uk**
## **A note on language**
Within this document the terms ‘woman’ and ‘women’s health’ are used. However, it is important to acknowledge that it is not only people who identify as women for whom it is necessary to access women’s health and reproductive services in order to maintain their gynaecological health and reproductive wellbeing. Gynaecological and obstetric services and delivery of care must therefore be appropriate, inclusive and sensitive to the needs of those individuals whose gender identity does not align with the sex they were assigned at birth.
2
**Royal College of Obstetricians and Gynaecologists**
## **Welcome from our Chair**
## **For the year ended to 31 December 2025**
## **Welcome from our Chair**
I am pleased to introduce the annual report for the Royal College of Obstetricians and Gynaecologists for 1 January 2025 to 31 December 2025. This year marks the conclusion of our 2020–2025 strategy, providing an opportunity to reflect on a period of progress, growth and global impact. This report highlights the College’s achievements in the UK and internationally as we have continued to advance our mission to improve the health of women and girls.
Throughout the year, the College has maintained its strong focus on supporting the profession and driving improvements in standards of care. Our continued growth is reflected in record global membership, increased access to examinations and training, and strengthened engagement with our international communities. At the same time, we have expanded our influence, shaping policy and contributing to progress on key issues in women’s health including maternity safety, gynaecology waiting lists and health inequalities.
Our global programmes and partnerships have continued to improve access to high-quality care, while our education and training initiatives are equipping healthcare professionals with the skills needed to meet the challenges of modern practice. Alongside this, we have strengthened our commitment to sustainability, inclusion and collaboration, ensuring the College is well positioned for the future.
These achievements reflect the dedication and expertise of our members, volunteers and staff, whose commitment continues to drive the College forward. I would like to thank everyone who has contributed to our work over the past year. As we look ahead to our new strategy and our centenary in 2029, we remain focused on delivering meaningful change and improving outcomes for women and girls worldwide.
## **Baroness Tessa Blackstone Chair, Board of Trustees**
3
**Royal College of Obstetricians and Gynaecologists**
## **Message from our Chief Executive Officer**
## **For the year ended to 31 December 2025**
## **Message from our Chief Executive Officer**
2025 has been a year of delivery, consolidation and forward planning for the RCOG, marking the final year of our 2020–2025 strategy. Over this period, we have strengthened our global reach, enhanced our offer to members and increased our influence on the issues that matter most to women’s health.
Our membership continued to grow, reaching 19,000 members across 124 countries. Over the course of the five-year strategy, membership increased by 25%, reflecting the College’s global relevance and our commitment to supporting obstetricians and gynaecologists at every stage of their careers. This growth, alongside a consistently strong retention rate of 96%, demonstrates the value members place on their connection to the College and the support we provide.
Education and training have remained central to our work. In 2025, we delivered more examination places than ever before, with 10,941 candidates sitting our membership exams across 56 countries. Alongside this, we have continued to strengthen our educational programmes and resources, ensuring clinicians are equipped with the skills needed to meet the evolving demands of modern practice.
Our policy and public affairs work has further strengthened the College’s influence. We have continued to advocate for action on gynaecology waiting lists, maternity safety and inequalities in women’s health, contributing to national policy development and securing progress on key priorities, including increased investment in gynaecology services and continued momentum towards the decriminalisation of abortion.
As we conclude our current strategy, we also look ahead with confidence. In 2025, we developed a new fiveyear strategy for 2025–2030, setting out an ambitious vision for the College as a global leader in women’s health. This next phase will build on our strong foundations, ensuring we continue to support our members, influence policy and deliver meaningful impact.
I would like to thank our global membership for their continued commitment, expertise and support. It is through your dedication that the College is able to deliver its mission and improve the health of women and girls around the world.
## **Kate Lancaster, CEO**
4
**Royal College of Obstetricians and Gynaecologists**
## **Message from our President**
## **For the year ended to 31 December 2025**
## **Message from our President**
A few months into my term as President, I am incredibly proud to reflect on a year of significant clinical progress and collective impact across the Royal College of Obstetricians and Gynaecologists.
I would like to thank my predecessor, Ranee Thakar, and her team of officers for their leadership over the past year and throughout their term in office. Their work has certainly further strengthened the College’s role as a global leader in advancing women’s health.
Our members in the UK and globally, continue to demonstrate exceptional commitment to delivering highquality care for women and girls, often in complex and increasingly challenging environments. It is through their expertise and dedication that the College is able to drive improvements in clinical standards and outcomes.
This year, we have made further progress in improving the safety, quality and equity of care. The national rollout of the Avoiding Brain Injury in Childbirth programme is supporting safe maternity care, while our Maternity Service Standards Framework will help to reduce variation and improve consistency across services. The development of a new Patient Reported Experience Measure will also ensure that women’s voices are more consistently reflected in how care is designed and delivered.
We have continued to strengthen our focus on tackling inequalities in women’s health. New standards on cross-cultural communication and language support have been developed to improve access and safety for women who face barriers to care, while our wider work continues to address disparities in outcomes and experience.
Globally, the College has expanded its clinical impact through programmes that support healthcare professionals to deliver high-quality, evidence-based care. Our work to improve gynaecological health, expand access to safe abortion care and end harmful practices such as FGM/C is contributing to better outcomes for women and girls in underserved communities.
Alongside this, we continue to strengthen the clinical foundations of the profession. Our guidance, training and research initiatives, and our work to shape the future of surgical training, are ensuring that the profession of obstetrics and gynaecology continues to evolve to meet the needs of patients and professionals.
There is much to be proud of in what has been achieved over the past year. These successes reflect the strength of our global membership, and the impact we can have when we work together.
As we look to the year ahead, I am confident that, working with my team of officers and with our global membership, we will continue to build on this progress and deliver meaningful improvements in maternity safety and women’s health.
## **Alison Wright, President**
5
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
The Trustees present herewith their report and the financial statements for the year ended 31 December 2025. The Trustees have adopted the provisions of the Statement of Recommended Practice (SORP) “Accounting and Reporting by Charities” (FRS 102) in preparing the annual report and financial statements of the charity.
The financial statements have been prepared in accordance with the accounting policies set out in notes to the accounts and comply with the charity’s governing document, the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland published in October 2019.
## **Progress against the Royal College of Obstetricians and Gynaecologists strategic goals**
## **Goal 1: We will develop our membership offering to best meet the needs of our members globally and the women they serve and expand our reach across the international O&G community.**
Recognised worldwide for excellence in postgraduate medical education, the College continued to provide comprehensive support to members throughout their careers, delivering education and training programmes, examinations, professional development opportunities, expert guidance and international collaboration.
In 2025, membership grew by 4.5% to a record high of 19,000 members across 124 countries. There are now more obstetricians and gynaecologists trained to the highest standards around the world, meaning more women and girls are receiving high-quality care. Annual member retention remained strong at 96%. Across the five-years of this strategy period, our membership grew by 25%.
The College welcomed more than 700 new Fellows and Members at nine admission ceremonies during the year, including ceremonies held in London alongside the RCOG World Congress and in Chennai, India, in partnership with the All India Co-ordinating Committee (AICC). These ceremonies reflected the global nature of the College’s membership and its continued growth around the world.
A record 10,941 candidates sat the College’s three membership examinations across more than 70 countries in 2025, representing a 6% increase on 2024 and a 37% increase across the five-year strategy period. This expanded access is equipping more doctors with essential knowledge and skills and improving women’s access to skilled obstetric and gynaecological care.
To support this growth while maintaining the highest standards, the College recruited and trained more than 120 new clinical and lay examiners in 2025. This brought the total number of Members and Fellows contributing to the Part 3 examination to 783 across 24 countries. Greater diversity within the examiner cohort has helped ensure assessments are fair, robust and representative of the global candidate base.
Access to the MRCOG qualification continued to expand with the opening of two new Part 3 examination centres in Pakistan and Saudi Arabia. These centres will allow more doctors in South Asia and the Middle East to complete the MRCOG examination closer to home and progress in their careers, supporting the development of a skilled global O&G workforce.
6
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
The College continued to review and enhance its examination revision resources. In 2025, 430 validated questions were available to support MRCOG Part 1 candidates, and a Task and Finish Group developed 200 new single best answer questions for Part 2. These developments strengthen the quality, validity and accessibility of RCOG Learning resources.
Evaluation of formal structured training continued during the year to assess what is working well within O&G Curriculum 2024 and where further improvement is needed. A report summarising the findings, alongside an action plan, will be shared with the General Medical Council in early 2026.
In 2025, 192 doctors completed the UK O&G specialty training programme, which involves a minimum of seven years of structured training. These doctors were recommended to the General Medical Council to receive their Certificates of Completion of Training and are now qualified to enter the specialist workforce, contributing to the delivery of NHS maternity and gynaecology services.
A major milestone was achieved in October 2025 with the signing of the Malaysia Accreditation Agreement with the Ministry of Health Malaysia, the Academy of Medicine of Malaysia and O&G Society PROGEN. From July 2026, the College’s new accreditation model will be embedded within Malaysia’s national postgraduate training system, supporting national ambitions to expand the number of trained O&G specialists.
The College delivered 48 educational events and courses worldwide, attended by 3,657 delegates. More than 36,200 CPD credits were awarded to members and healthcare professionals who completed courses, attended conferences or undertook online learning activities. This supported ongoing professional development, revalidation and the delivery of high standards of care. New educational events were delivered on chronic pelvic pain and the use of ultrasound to diagnose endometriosis, supporting earlier diagnosis and improved outcomes for women affected by these conditions.
The College continued to provide guidance and support to help professionals excel. In June 2025, 3,165 attendees from 95 countries participated in the RCOG World Congress in London. With 250 speakers and the largest programme in its history, the Congress brought together clinicians, researchers and educators from around the world to share knowledge, innovation and best practice, supporting improvements in clinical care and women’s health outcomes.
The College’s census of the UK O&G workforce found that 65% of respondents are at risk of burnout. This evidence will be used to better understand the support members need and to call on government for additional investment in women’s healthcare. As part of this work, the College will update its _Supporting our Doctors_ services, including peer-to-peer support, guidance on returning to work after parental leave, sickness or career breaks, and workplace champions to address undermining and bullying behaviour.
In February 2025, the College published the _O&G Surgical Skills Interim Report_ , which found that long gynaecology waiting lists, workforce shortages and increasingly complex surgeries have limited trainees’ exposure to surgical training. The report sets out recommendations to improve surgical training and forms part of a wider programme of work to shape the future of O&G surgical training in the UK and globally.
7
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
Nine new pieces of evidence-based guidance and patient information were published during the year, and 15 existing resources were updated. This supports members to enhance clinical practice, strengthen decisionmaking and deepen professional knowledge, while providing women and families with clear, reliable and upto-date information to support informed choices about care.
As part of the College’s work to address racism and discrimination in the profession, _Race Equity in the Workforce_ was launched as a free online resource. The resource supports leadership, managers and staff to tackle discrimination and promote inclusive workplaces, covering anti-discrimination leadership, inclusive teams, support for doctors, empowerment and psychological safety.
The College held 28 elections during the year to appoint clinical leaders, including the new President and VicePresident team, who oversee the clinical, educational, professional, academic and ethical activities of the organisation. The College also continued to work closely with its International Representative Committees, which provide leadership and act as a point of contact for members outside the UK. In 2025, the College supported the Committees by convening a meeting to showcase their work and engage members with the new 2025–2030 strategy.
Volunteers continued to play a vital role in delivering the College’s work. In 2025, more than 2,200 clinical experts supported activity across clinical quality, research and patient safety; education, examinations and professional development; and support for the O&G profession at all career stages. Volunteering enables members to contribute expertise, develop new skills and help shape clinical practice and patient care globally.
## **In 2026, the RCOG will:**
- Continue to expand access to high-quality education by developing and scaling up franchise courses, enabling more clinicians to benefit from College-accredited training and supporting improvements in clinical practice and outcomes in women’s health.
- Grow and sustain the College’s global membership by promoting the value of membership and the benefits of completing College examinations, while retaining existing members through tailored support at different stages of their careers.
- Strengthen support for those with associate status, including doctors in training outside the UK, SAS doctors, locally employed doctors and established overseas doctors not on the MRCOG training pathway, ensuring they are better supported throughout their professional journeys.
- Improve support for College volunteers to ensure they feel valued, connected and informed, including the development of clear information outlining the benefits and opportunities associated with volunteering.
- Continue to develop and refresh the _Supporting our Doctors_ resources to ensure wellbeing services meet the needs of members at all career stages and support improvements in workplace culture and behaviour.
8
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Goal 2: We will leverage our strong brand and world-renowned reputation to develop partnerships and influence UK and international policy to improve women’s health globally.**
Through its partnerships, research, advocacy and influencing activity, the College continued to raise the profile of women’s healthcare and standards of professional practice in the UK and internationally.
Improving maternity safety remained a core priority. The College reviewed and updated its _Maternity Service Standards Framework_ , which aims to reduce unwarranted variation in maternity care across the UK and improve outcomes for mothers and babies. The framework supports commissioners and service providers to deliver high-quality maternity services that are more consistent, safer, equitable and compassionate.
The College continued to strengthen the use of evidence and lived experience to drive improvement in maternity and neonatal care. In collaboration with the London School of Hygiene and Tropical Medicine, work progressed to develop a new Patient Reported Experience Measure for maternity and neonatal services. From summer 2026, women and families will be able to provide structured feedback on their experience of care, supporting service improvement and accountability. Patient involvement was also embedded across College activity, including through the RCOG Women’s Network, which continued to contribute as Lay Examiners, committee members and speakers at College events, including World Congress.
The College worked with partners through the National Maternity and Perinatal Audit to provide a comprehensive picture of birth trends and outcomes. _State of the Nation_ , published in September 2025, reported on 592,594 births in England, Scotland and Wales in 2023 and represented the largest evaluation of maternity services in the world.
The Maternity Safety Independent Advisory Group provided independent expertise and advice to the College in support of its maternity safety agenda. Established in 2023, the group brings together professionals with specialist knowledge of best practice alongside people with lived experience, supporting the College’s work to address matters of concern for members and the women and families they serve.
The College progressed the national rollout of the Avoiding Brain Injury in Childbirth (ABC) programme across England, following two successful pilot phases delivered in 12 maternity units. Delivered in collaboration with the Royal College of Midwives and The Healthcare Improvement Studies Institute at the University of Cambridge, the programme supports maternity teams to better recognise and respond to fetal deterioration during labour and to manage impacted fetal head at caesarean birth, helping to reduce avoidable harm.
Alongside the Royal College of Midwives, the College hosted a maternity safety summit to support NHS trusts and integrated care boards to address the challenges facing maternity and neonatal services. Delegates heard from the Secretary of State for Health and Care about the forthcoming maternity review and plans to support services to improve safety and quality.
To support equitable access to care, the College published _Cross-Cultural Communication and Language Support: Standards for Maternity Care and Women’s Health_ in December 2025. These standards set clear expectations for NHS providers and commissioners, including that women who do not speak English should
9
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
have access to free professional interpreters at all maternity appointments, helping services to address inequalities and improve safety.
The College continued to influence policy and advocate for change in the UK. Research published in 2025 found that only 5% of women believe the UK Government treats women’s health as a priority, while 46% reported difficulty accessing women’s health services. The College used these findings to publish an open letter to the Government on International Women’s Day, co-signed by 48 organisations, calling for women’s health to be prioritised.
A significant milestone was achieved on the campaign to remove women from the criminal law related to abortion in England and Wales. Working with partners, the College helped secure parliamentary support so women no longer face criminal investigation or prosecution for ending their own pregnancy. The College continues to advocate for the amendment to be supported in the House of Lords so abortion is recognised and regulated as essential healthcare.
The College influenced the development of the UK Government’s 10 Year Health Plan, calling for sustained investment in women’s health hubs, fully funded and safely staffed maternity services, and increased investment in gynaecology, infrastructure, digital systems and research. These priorities were reinforced through the College’s Women’s Health Manifesto.
Following sustained advocacy, the UK Government announced a review of the Women’s Health Strategy for England. The College published an analysis of progress against the 2022 strategy, identifying areas of improvement alongside significant gaps, and continued to work with the Department of Health and Social Care to target areas most in need of action.
The College furthered its campaign on gynaecology waiting lists following the launch of _Waiting for a Way Forward_ , maintaining an interactive data dashboard and providing tailored briefings to MPs ahead of parliamentary debates. In January 2025, the UK Government announced increased funding for gynaecology as part of the Elective Care Plan.
The College submitted evidence to parliamentary inquiries on the early years sector, obesity, reproductive health, FGM and health inequalities, and briefed MPs and Peers on key debates and legislation, including maternity services, the Women’s Health Strategy for England and the Tobacco and Vapes Bill.
In 2025, the College issued 49 press releases and statements and responded to more than 400 media enquiries, generating over 3,500 pieces of coverage across broadcast, national and regional media. This sustained media coverage focused on critical women’s health issues including gynaecology waiting lists, workforce pressures, maternity safety, reproductive rights and wider gaps in women’s health.
The College also maintained a strong global advocacy presence. It participated in the 69th session of the United Nations Commission on the Status of Women in New York and the 78th World Health Assembly in Geneva, engaging with governments and international partners on priorities for women’s sexual, reproductive and maternal health.
10
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
In Nigeria, the College’s Essential Gynaecological Skills training was included in the Government of Nigeria’s Safe Motherhood Strategy. Government representatives from six states expressed interest in adopting the training within state-level plans. Working with the Africa Centre of Excellence for Population Health and Policy and the Society of Gynaecology and Obstetrics of Nigeria, the College continued delivery of the Gynaecological Health Matters programme in Kano and Abuja states. The programme trained 20 expert trainers and 180 healthcare providers, with training materials validated and adopted by Government.
The College expanded its global work to end female genital mutilation/cutting by strengthening doctor training in Egypt, developing new partnerships in South and Southeast Asia, and enhancing its programme to equip doctors with advocacy and influencing skills. In partnership with Equality Now, ARROW, Orchid Project and Asia Network, the College delivered the first analysis of the medicalisation of FGM/C across South and Southeast Asia, providing evidence and clear recommendations to prevent harm to girls in healthcare settings.
## **In 2026, the RCOG will:**
- Use its consultative status with the United Nations Economic and Social Council to elevate neglected reproductive and maternal health issues globally, strengthening partnerships with UN agencies, civil society and advocacy networks to advance women’s health and gender equality.
- Secure funding to deliver targeted global health programmes on gynaecological healthand the elimination of female genital mutilation/cutting in countries including Egypt, Nigeria and Rwanda.
- Work with partners and parliamentarians to secure final legislative support for the decriminalisation of abortion for women, ensuring reform is enacted in 2026.
- Publish a policy position statement on digital transformation in the NHS, setting out the digital priorities for women’s health services and the O&G profession.
- Sustain pressure for investment in women’s health hubs and action on gynaecology waiting lists, maintaining the College’s Elective Recovery Tracker and using robust data analysis to inform public debate and policy decisions.
## **Goal 3: We will become more resilient, accessible and influential through the delivery of a comprehensive digital transformation programme to ensure our research, educational and clinical products have benefit globally and drive up standards in women’s health.**
The College continued to deliver its digital transformation programme to expand the reach and accessibility of its educational resources, clinical guidance and information, ensuring members and the wider O&G community can access high-quality materials, in support of their career, quickly and easily.
In 2025, the College reached more people globally through its digital channels than ever before. Website visits increased to 5.2 million, a 20% increase compared to 2024, reflecting continued growth in demand for clinical guidance, patient information, educational resources and courses. This expansion supports clinicians worldwide to deliver safe, evidence-based care.
Progress continued on the development of a new customer relationship management (CRM) system, which will improve services for members and make it easier to manage RCOG membership online. This work is
11
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
central to improving the overall member experience and enabling more personalised engagement with the College.
The College further enhanced its online learning platform, RCOG Learning, improving navigation and course discovery and introducing more interactive learning elements. New resources were launched on topics including maternal vaccination in pregnancy and haemolytic disease of the fetus and newborn. Now in its third year, RCOG Learning attracted more than 28,000 visitors in 2025 and achieved a learner satisfaction score of 6.06 out of 7.
The College continued to support the delivery of high-quality education through digital and blended learning models. Sixty-four trusted external organisations and individuals were supported to deliver College-branded franchise courses in person across the UK and internationally, reaching a further 894 clinicians. These partnerships extend access to RCOG training, strengthen regional collaboration and support consistent standards of care worldwide.
The College’s webinar programme continued to provide timely education on key clinical topics. In April and May, more than 16,000 people registered for the webinar _Prediction and Prevention of Pre-eclampsia_ , making it the most popular event in the College’s history. Average registrations for the free webinar programme reached 3,833 in 2025, representing a 159% increase compared with 2024.
To maintain fairness, consistency and inclusivity within assessments, the College launched new online refresher training modules for MRCOG examiners, including content on unconscious bias and differential attainment. The digital format enables examiners around the world to complete training flexibly while maintaining high standards in the Part 3 examination.
The College also improved access to its Green-top Guidelines, which provide clinicians with evidence-based recommendations for the management of specific conditions. User research with UK and international members informed a redesign of the Green-top Guideline webpages, introducing a new clinical categorisation approach. This resulted in an 8% increase in page views and a 61% increase in engagement with the content.
To further support professional development, eight CPD resources were redeveloped to include audio, video and interactive elements, as well as reflective learning tasks. These resources focused on common and impactful clinical topics including birth trauma, hirsutism and heavy menstrual bleeding, supporting clinicians to improve care for women and girls.
The College continued to promote careers in obstetrics and gynaecology through targeted digital engagement. In May 2025, the College hosted a virtual careers day for medical students, foundation doctors, specialty and specialist doctors, locally employed doctors and those considering working in the UK. More than 400 delegates registered, and recordings were made available to extend access beyond the live event.
Support for international medical graduates (IMGs) was strengthened through the dedicated IMG hub on the College website. Content and links were reviewed and updated to improve accessibility, and the hub was promoted through the College’s _Supporting our Doctors_ portfolio to help IMGs navigate career options in UK O&G practice.
12
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
In October 2025, the College supported SAS Week to raise awareness of the roles of specialty and associate specialist (SAS) doctors and locally employed doctors (LEDs). Website content was published to highlight career pathways and encourage a diverse range of doctors to pursue careers in O&G.
## **In 2026, the RCOG will:**
- Continue work to review its course portfolio to ensure the right balance of in-person and virtual delivery, improving access, reducing waiting times and better meeting members’ learning needs.
- Strengthen data protection by investing in advanced cyber security tools and services to safeguard members’ personal information.
- Complete the evaluation of the Training ePortfolio and use the findings to refine training provision, ensuring it remains responsive to learners’ needs.
- Explore the responsible use of artificial intelligence to improve access to Green-top Guidelines, enhancing usability and enabling clinicians and the public to find relevant information more efficiently.
- Further develop the RCOG Learning platform by refreshing existing resources and introducing new content aligned with College priorities, including special interest training, surgical skills education and updated examination preparation materials.
- Complete rollout of the new customer relationship management system to streamline processes and improve the overall member experience.
## **Goal 4: We will ensure our financial and environmental sustainability through delivery of all of the above objectives and contribute to a significantly reduced carbon footprint.**
As part of its ongoing commitment to environmental sustainability and equity, the College continued to take action to reduce its carbon footprint, support low-carbon care, and strengthen collaboration across the women’s health sector.
The College concluded the Green Maternity Challenge in 2025, having supported nine multidisciplinary teams across the UK to develop, deliver and measure carbon-reduction initiatives within maternity services. Teams received training and mentoring to address carbon and inequity hotspots in maternity care, and shared learning from the programme at a conference in March attended by more than 100 delegates. Insights from this work informed the publication of _The Green Maternity Report_ , which set out eight evidence-based recommendations to support maternity teams and leaders to reduce carbon emissions while improving safety, experience and equity. Recommendations included streamlining outpatient care, reducing travel, minimising waste during labour and birth, and ensuring women receive the right care first time to improve outcomes and sustainability.
The College continued to reduce its organisational carbon footprint. The RCOG offices at Union Street transitioned to electricity supplied entirely from green energy, and the College continued to benefit from its existing solar panels. Three farmstands were installed to grow herbs and salads for staff and tenants, reducing the need for fresh deliveries and supporting sustainable food practices. Through a blended delivery model for education and events, the College engaged 3,657 delegates across 20 in-person, 23 virtual and five hybrid activities. With 66% of participants attending virtually, this approach maximised accessibility while reducing travel-related emissions and overall costs.
13
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
Collaboration across the women’s health sector was further strengthened through the shared space at the RCOG offices. In 2025, two new women’s health organisations moved into our Union Street building, taking the number of organisations within the women’s health hub to 16. The provision of meeting rooms and breakout facilities supported collaboration while helping partner organisations to manage costs.
The College continued to work collaboratively to support innovation and sustainability in women’s health. Plans are in place to develop a Women’s Health Innovation Hub, designed to accelerate research and technology addressing unmet needs in women’s health and to support clinical innovators within the College’s membership. The College worked with partners including Innovate UK and the Association of British HealthTech Industries and contributed to the Femtech Accelerator to ensure alignment with established leaders in this field.
The College’s work to foster an inclusive organisational culture continued to be recognised. In 2025, the College received a second consecutive Silver Talent Inclusion and Diversity Evaluation (TIDE) award from Onvero (formerly the Employers Network for Equality and Inclusion). The College’s score increased from 74% to 76%, placing it in the top third of participating organisations and the top 20% of charities.
Key actions under the 2021–2025 Equality, Diversity and Inclusion action plan were completed during the year. These actions helped make the College a more inclusive and representative place to work and included delivering EDI and wellbeing events, strengthening mental health support through Mental Health First Aiders and mindfulness training, and launching inclusion passports to support staff with disabilities. Mandatory active bystander training was introduced alongside a revised Anti-Bullying and Harassment Policy, and the College participated in Leonard Cheshire’s Change 100 scheme to support disabled students and graduates. The College also achieved Disability Confident Employer status and prepared a workforce diversity profile to be published in early 2026.
In 2025, the College also developed a new organisational strategy for 2025–2030. As the College approaches its centenary, the strategy sets the direction for a defining period ahead, reaffirming the College’s commitment to advancing the health and rights of women and girls worldwide while ensuring long-term financial, environmental and organisational sustainability.
## **In 2026, the RCOG will:**
- Deliver its technology strategy to improve organisational efficiency and increase the responsible use of artificial intelligence across College operations.
- Take forward plans to develop a Women’s Health Innovation Hub, designed to accelerate research and technology addressing unmet needs in women’s health and to support clinical innovators within the College’s membership.
- Implement a smart buildings strategy at Union Street, enabling heating, cooling and lighting systems to be monitored remotely and to respond dynamically to changing weather conditions, improving energy efficiency.
- Develop a new Equality, Diversity and Inclusion plan aligned with the College’s 2025–2030 strategy, ensuring inclusion remains a core organisational priority.
- Launch a new learning and development programme for leaders, managers and new starters, providing mandatory and core training to support delivery of the College’s new strategy.
14
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Financial Review**
## **2025 Overview**
These accounts cover the 12-month period from 1 January 2025 to 31 December 2025.
In terms of the College’s financial performance for the 12-month period to December 2025, the Board of Trustees is pleased to report an I&E surplus of £139k, before unrealised investment gains. The final period end position after unrealised investment gains is a surplus of £595k.
||**31 December**
**2025**
**£**|**31 December**
**2024**
**£**|
|---|---|---|
|Continuing Unrestricted|331,863|488,816|
|Endowment|(70,648)|76,830|
|Continuing Restricted funds|(122,549)|(760,799)|
|**Total surplus / (deficit) before investment gains/(losses)**|138,665|(195,153)|
|Unrealised Investment gains/losses|456,236|1,241,966|
|**Total Surplus/(deficit)**|**594,902**|**1,046,813**|
Contributing factors to this year’s results include:
## **Unrestricted**
- The underlying operational performance for the 12-months to 31 December 2025 before unrealised investment gains was £332k. The comparative figure for the 12 months to 31 December 2024 was £489k.
- Overall total income has increased by 5% from 2024. This is largely due to the rise in membership revenue in 2025. The overall trend indicates continued resilience in subscription, Congress and examination-based income streams, while externally funded activities remain more volatile and sensitive to market conditions.
- Contracts and Grants income has fallen this year, and this is largely due to the funding environment and lack of funding renewals with partners.
- Unrestricted expenditure has increased by 6%, pay cost increased by £187k (2%) from 2024. Expenditure is well controlled with underspend and cost improvement savings made during the year on both capital and revenue projects.
- Charitable expenditure for the year ended 31 December 2025 was £20.3m compared to £19.8m in 2024, an overall increase of £464k (2%).
15
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Endowment**
- The endowment income of £91,392 (2024 £144,220) is derived from the Sarasin investment portfolio and other charitable donations.
## **Restricted**
- The College’s restricted activities delivered during the period were funded by a combination of grant funding received in the year: £495,791 from the Tommy’s Charity for the Tommy’s National Centre for Maternity Improvement, £76,245 from The Gates Foundation for the Tommy’s Pathway Pearls project, £77,217 from the Tommy’s Charity for procurement, £155k from Hologic for the Surgical Skills Project, £64,965 from the Global Health Partnerships Nigeria Programme Extension, and £29,899 from the A. G. Leventis Foundation.
## **Balance sheet**
Total funds at 31 December 2025 stood at £61,113,360. £42.1m of this is in tangible fixed assets, intangibles represented £1.2m, Investments £17.9m, and £30.8k is in net current liabilities.
## **Reserves**
84% of the College’s total reserves are in the form of unrestricted reserves, 9% in restricted funds and 7% in permanent and expendable endowment funds.
## **Designated funds**
Designated funds reflect a total of £43,457,119 (2024: £42.0m). Fixed assets represent £40.6m of the designated funds (see note 25 for complete breakdown), this includes the heritage fund of £300k representing the valuation of historic donations of furniture, books, pictures and equipment. Details of all remaining funds are included in note 25 on pages 62 to 63 of the Annual Accounts.
## **Policy on general reserves**
The College’s General Reserves Policy explains why the College holds reserves. It gives confidence to stakeholders that the College’s finances are being properly managed and provides the Trustees’ assessment of future funding needs and the overall financial resilience and sustainability of the College.
The College holds general reserves to cover unexpected changes in income and expenditure, allowing the organisation to continue to operate. The general reserves also allow the College to deliver strategic priorities and take advantage of new opportunities, which can potentially generate future income.
The College has adopted the Charity Commission CC19 guidance on Charity Reserves: building resilience. The CC19 guidance states that charities adopt a risk-based approach to reserves by holding sufficient amounts to
16
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
accommodate fluctuations in funding streams and expenditure, ensure adequate cashflow, to enable future innovation and to ensure that charities can be ‘generative’ in their work i.e. find new ways to achieve impact. The RCOG’s reserves policy reflects financial risks and commitments, including the following:
- Working capital requirements.
- Short-term increases in spend for known liabilities.
- Contingencies for those risks on the corporate risk register which potentially could have a serious financial impact.
The College’s costs relate primarily to staff and operations, plus expenditure related to the delivery of external projects. The externally funded projects are dependent on grants being awarded and funded, therefore, such costs are not included in the calculation of the general reserves. The main consideration for the College’s general reserves hence is salary and its own operating costs.
The minimum level of reserves required by the Trustees based on the 2025 Budget approved by the Board of Trustees in November 2025 was £5.2m.
The total funds balance of £61,113,360 (2024: £60.5m) includes endowments, restricted funds, designated funds and general funds. Only a small proportion of the reserve is backed by unrestricted, freely realisable cash.
At 31 December 2025, the free reserves amounted to £7.8m (2024: £8.6m). This exceeds the required free reserve of £5.2m by £2.9m. Trustees consider the current level of free reserve to be within an acceptable margin. The reserves policy is reviewed on an annual basis.
The total of free reserves is calculated as follows:
|**RESERVES**|**2025**|**2024**|
|---|---|---|
|Total charity funds|61,113,360|60,518,458|
|Less permanent endowment funds|(472,899)|(447,055)|
|Less expendable endowment funds|(3,810,992)|(3,663,361)|
|Less restricted income funds|(5,531,951)|(5,789,093)|
|Less designated funds|(43,457,119)|(41,997,835)|
|**Total free reserves**|**£7,840,399**|**£8,621,114**|
The closing cash balance as at 31 December 2025 was £979,678 (2024: £2.7m). Investments valued at £17,880,891 (2024: £15.6m) are funds invested in short- and medium-term vehicles which generate a small but steady income.
## **Ethical and Responsible Investment policy**
The College has an Investment Advisory Panel advising and reviewing the College's overall investment strategy and asset allocation, ensuring that the College's investment is aligned with its charitable objectives. Moreover,
17
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
the Panel actively engages with the Investment Manager with regard to the investment environmental, social and governance (ESG) performance and actions. The Panel meets at least twice a year.
## **The key investment objectives within the RCOG’s formal investment policy statement are as follows:**
- The RCOG seeks to produce the best financial return within an acceptable level of risk.
- The investment objective of the endowment (considered long term) is to preserve and grow the capital value in real terms.
- The investment objective of the general restricted reserves (considered long term) is to generate a total return in excess of inflation over the long term whilst generating income to support the on-going activities defined by the restrictions.
## **Attitude to risk**
The key risk to longer-term reserves is inflation, and the assets should be invested to mitigate this risk over the long term. The Trustees understand that this is likely to mean that a significant percentage of the total investment will be concentrated in real assets (including equities, property and private equity), which will carry with them a number of risks, namely volatility and the potential for substantial capital fluctuation.
The primary mitigation against these risks is to adopt a long-term view and ensure that sufficient liquid assets are held to meet known liabilities and short-term spending requirements.
## **Ethical & Responsible Investment Policy**
The RCOG expects any investments made on its behalf to be suitable for a registered charity, with an expectation that the appointed Investment Manager acts as a responsible steward of the charity’s capital. The Trustees wish to embrace a sustainable investment strategy, avoiding direct investment in companies that earn revenue from the production of tobacco, or a material portion of their revenues from adult entertainment, alcohol, armaments, gambling and predatory lending and the extraction of thermal coal and production of oil from tar sands.
The College invests for the long term and expects its Investment Manager(s), as part of their investment research and analysis, to take account of ESG factors in the selection, ownership and sale of any potential investments. It is understood that any material risks and opportunities from ESG issues will influence the valuation of each company and security. As such, thorough management and analysis of these risks can lead to long-term financial benefits. Taking account of such considerations is seen as forming part of the investment managers’ day to day fiduciary duty.
The College has instructed its Investment Manager to adopt a strong focus on company ownership and the responsibilities that this entails, as stewards of the College’s capital. It is expected that the Investment Manager will pursue active engagement on corporate governance and strategy, as well as issues of social and environmental concern. The Investment Manager’s voting record and activity will be transparent and easily accessible, forming part of regular investment reporting.
18
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Fund management**
The total market value of investment portfolio as at 31 December 2025 was £17,880,891 (2024: £15.6m). The investment income received for the period was £342,081 (2024: £397k).
Further details on investments can be found in note 16 on page 52 of the Annual Accounts.
## **Fundraising**
The RCOG is registered with the Fundraising Regulator and has established fundraising policies, using the Code of Fundraising Practice as a guideline. College campaigns are run by an in-house team and we do not engage the services of commercial partners to raise funds on our behalf.
The College aims to follow best practice in all fundraising activities and to ensure that communications are carried out in accordance with members’ contact preferences.
A complaints procedure is in place to ensure any complaints received are dealt with promptly and handled in accordance with College policy. During the period of this report no complaints were received relating to our fundraising activities.
## **Pensions**
The College operates two pension schemes: the Defined Contribution Scheme (DCS), which is open to all staff, and the Defined Benefit Scheme (DBS), both operated through a separate trustee-administered fund. In May 2014, the College introduced an auto-enrolment section within the DCS. The DBS was closed to new members in 2003 and future accrual for active members ceased from 31 December 2014.
During the 12-month period, the scheme Trustees informed the College that the Defined Benefit Scheme was fully funded. The historic deficit repayment plan previously agreed with the employers up to 31 March 2027 was suspended and the Board of Trustees approved the commencement of the pension buy out project.
The insurance market’s response to the increased demand for DBS scheme buyouts has resulted in an increase in the cost of buyout premiums. The College is in active discussion with insurance companies to progress the buyout decision. The latest estimate is that an additional payment of £2.65 million will be required to deliver the buyout project.
The College has set aside within designated funds a long-term liability fund of £2.51million which will be utilised to fund the cost of buyout. The Board of Trustees has agreed to use the unrestricted surplus generated in this financial period to increase the value of the fund by £240k which will be utilised to fund the cost of the buyout.
At 31 December 2025, the College’s FRS102 actuarial valuation showed that that the fair value of the scheme’s assets exceeded the scheme’s liabilities. After discussion with our auditor, the College’s Trustees have
19
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
determined that the prudent approach is not to recognise the net assets within the accounts. Further details of the schemes can be found in note 27 on pages 64 to 67 of the Annual Accounts.
## **Trading Company**
The College has a commercial arm, RCOG Trading Limited, whose principal activities have traditionally comprised of the hire of rooms and the provision of catering facilities and accommodation under a contract with Graysons.
The results for the financial period ending 31 December 2025, demonstrate the continued recovery of trading activities post the COVID-19 interruption, as well as that the on-going work with Grayson is showing some growth as the College embarks on a journey to diversify its commercial activities going forwards.
The College’s trading company generated a surplus of £467,001 in the year to 31 December 2025 (2024: £589k), which was wholly and exclusively gifted to the parent company, RCOG charity. These results are consolidated into the accounts of the College.
## **Going concern**
The 2026 Budget approved by the Board of Trustees in November 2025 has an unrestricted surplus of £300k.
The 2026 budget planning process was improved to better align with departmental work plans, alongside other improvements, including a zero-based budgeting approach. This process will be further refined to agree the budget for 2027.
Trustees continue to monitor both global financial uncertainties and inflationary pressures on our cost base, which may potentially impact on the demand for our products and services.
The College has mechanisms in place to control costs to address a slower pace of income generation, and has successfully increased its membership, examinations and trading income.
The forecast year end position for 2026 is £300k.
The College presents a costed financial risk register the Finance & General Purposes Committee at each meeting.
The Trustees are satisfied that the College can continue operating for the foreseeable future and that there are no material uncertainties around going concern status for at least 12 months, following approval of these financial statements.
20
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Governance**
## **Structure**
**----- Start of picture text -----**
Council
Removals and Disciplinary, Workforce Board Global Health Board Education Board Academic Board Membership Board Clinical Quality Board
Reinstatements
Committee
Health CommitteeTrainees' Global Education Quality Assurance Portfolio Pathway Advisory Group CommitteeGenomicss Northern Ireland Committee Assurance GroupClinical Quality
Committee
Welsh Executive Guidelines
Committee Committee
Accreditation Excamination and
Project Board Assessment
Committee
Scottish Committee Patient Safety
Committee
Professional
Training Evaluation Committee Development Committee SAS/LED Committee Patient Information
Committee
British
eLearning Editorial Board National Trainees' Committee Undergraduate Society of Scientific Advisory Committee
Obstetrics and
Gynaecology
MTI Committee TOG Editorial Board
RCOG Women's
Network
RCOG Retired
Fellows and
Members
Committee
**----- End of picture text -----**
**The Board of Trustees** , chaired by an independent Chair, combines both clinical leadership with wider expertise essential to charity governance. Its membership includes six Obstetrician and Gynaecologist Trustees – the President, the Senior Vice President, one other Vice President, a Member or Fellow elected from Council and two Members or Fellows of the College in active practice. The Board also currently includes four Trustees (including the Chair) from a range of professional backgrounds. The Board met on six occasions in 2025.
21
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
The Board of Trustees scrutinises the financial, business and legal matters of the College and is the ultimate decision-making body. The work of the Board is supported by four Board subcommittees and Council.
Board delegated responsibilities to subcommittees, Council and the Executive are captured in a Schedule of Matters Reserved and Delegation. Day to day management of College business is led by the Executive team.
**Council** is responsible for developing policies and activities spanning all clinical and professional matters for women’s health. Chaired by the President, Council meets on five occasions during each year. Its members include the Officers of the College, Fellows and Members of the College, including 20 elected Fellows and 13 elected Members, two Trainee representatives, the Chair and Vice Chairs of the Women’s Network and the President of the College of Sexual and Reproductive Health.
The **Finance and General Purposes Committee** has delegated power to perform, on behalf of the Trustees, matters of specified business. It is responsible for the financial scrutiny of the College, including reviewing management accounts and recommending the annual budget to Trustees for approval.
The **Audit and Risk Committee** (ARC) provides the Trustees with an independent assessment of the College’s statutory financial position and accounting affairs, with the objective of providing further assurance of the quality and reliability of the financial information. It also oversees the systems of governance, risk management and internal control across the whole of the College’s activities. It meets not less than three times a year.
The **Equality, Diversity and Inclusion Committee** (EDIC) supports the work of the Board to ensure that the principles of EDI are embedded in the organisation and helps to deliver the charity’s public benefit. During the year, the Committee continued to oversee the delivery and maintenance of an effective EDI action plan across the whole of the College’s activities, which supports the achievement of the organisation’s objectives and strategic goals. The EDI Committee meets twice annually.
The Board governs the remuneration of Executive Directors and other RCOG staff via the **Nominations and Remuneration Committee** . The Committee meets at least annually.
The **Executive team** is made up of the CEO and the Executive Directors as listed on page 24. The Executive team supports the CEO in the management of the College’s performance and delivery of the College Strategy as a global organisation in line with legal and regulatory requirements and the College’s governing documents. It focuses on strategic leadership, management and direction, people, premises and infrastructure, ensuring the effective management and prioritisation of resources to deliver the College strategy and the Charity’s Objects.
## **Board of Trustees**
Chair Baroness Tessa Blackstone President Ranee Thakar/Alison Wright (to Dec 2025/with effect from (wef) Dec 2025) Senior Vice President Hassan Shehata/Andrew Leather (to Dec 2025/wef Dec 2025) Vice President Geeta Kumar/Sherif Abdel-Fattah (to Dec 2025/wef Dec 2025)
22
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
RCOG Fellow Steven Thornton RCOG Member John Heathcote RCOG Council Representative Alastair Campbell/Alastair McKelvey (to Dec 2025/wef Dec 2025) Trustee Roy Clarke Trustee Noah Franklin Trustee Leila Pilgrim **Council** President Ranee Thakar/Alison Wright (to Dec 2025/wef Dec 2025) Senior Vice President Global Health Hassan Shehata/Sherif Abdel-Fattah (to Dec 2025/wef Dec 2025) Vice President Education Ian Scudamore/Melanie Tipples (to Dec 2025/wef Dec 2025) Vice President Clinical Quality Geeta Kumar/Jenny Barber (to Dec 2025/wef Dec 2025) Vice President Membership & Workforce Laura Hipple (to Dec 2025) Senior Vice President Membership Andrew Leather (wef Dec 2025) Vice President Workforce Sujeewa Fernando (wef Dec 2025) Vice President Academia & Strategy Asma Khalil (to Dec 2025)
## _**Elected Fellows**_
London: North, Central, East & NW Joseph Iskaros London: South Dudley Robinson Eastern England Andrew Leather/Alastair McKelvey (to Jul 2025/wef Jul 2025) Northern/Yorkshire/Humber Swati Jha South West Philip Rolland/Rachna Bahl (to Jul 2025 /from Jul 2025) North West Andrew Pickersgill Kent Surrey & Sussex Melanie Tipples/Sridevi Sankaran (to Dec 2025/wef Dec 2025) Thames Valley & Wessex Fatima Hussain/Aparna Reddy (to Jul 2025/wef Jul 2025) East Midlands Mausumi Das West Midlands Justin Clark Wales Sujeewa Fernando/Manju Nair (to Dec 2025/wef Dec 2025) Scotland Colin Duncan/Evelyn Ferguson (to Jul 2025/wef Jul 2025) Alastair Campbell/Paul Mills (to Jul 2025/wef Jul 2025) Republic of Ireland Dr Suzanne O’Sullivan Northern Ireland Dr Hans Nagar Middle East and North Africa Sherif Abdel-Fattah/Ahmed Khalil (to Dec 2025/wef Dec 2025) America/Australasia/Pacific Rim Peter von Dadelzsen Sub-Saharan Africa Dilly Anumba/Samson Agwu (to Jul 2025/wef Jul 2025) South Asia Jyotsna Acharya/Santanu Acharya (to Jul 2025/wef Jul 2025) Europe Stergios Doumouchtsis
## _**Elected Members**_
London: North, Central, East & NW London: South East of England Northern/Yorkshire/Humber South West
Diane Nzelu Javaid Muglu Peter Harris Hannah Mistry Alison Wiggans
23
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
North West Vacant Kent, Surrey & Sussex Thames Valley & Wessex Ganga Verma East Midlands West Midlands Scotland Hanan Mustafa Ireland Helen Goodall Wales Aditi Miskin
Vacant Chimwemwe Kalumbi Ganga Verma William Dudill/Frances Hills (to Jul 2025/wef Jul 2025) William Parry-Smith/Archana Hatti (to Jul 2025/wef Jul 2025)
## _**Members**_
Chair Trainees’ Committee Kat Barton Vice Chair Trainees’ Committee Abby Hyland SAS / LED Lead Eman Toeima Women’s Voices Lead Jane Plumb MBE Vice Chair Women’s Network (rotating) Freya El Baz and Emma Crookes President, College of Sexual and Reproductive Healthcare
Janet Barter/Zara Haider (to Sep 2025/wef Sep 2025)
## **Executive Director Team**
Chief Executive Executive Director of Education and Quality Executive Director of Finance and Commercial Executive Director of External Affairs Executive Director of Membership and Global
Kate Lancaster Carly Edwards Ashley Wang Ben Butler Kristen Morgan
## **Patron**
Her Royal Highness, Catherine, Princess of Wales
## **Advisers**
## **External Auditor**
Azets Audit Services First Floor, River House 1 Maidstone Road Sidcup Kent DA14 5RH
## **Internal Auditor**
RSM Risk Assurance Services LLP The Pinnacle 170 Midsummer Boulevard Milton Keynes
24
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
Buckinghamshire MK9 1BP
**Banker** Barclays Bank plc Hanover Square Corporate Banking Group PO Box 15163H 50 Pall Mall London SW1A 1QD **Solicitors** Hempsons Bates Wells 100 Wood Street 10 Queen St, Place London EC2V 7AN London EC4R 1BE
25
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Trustee appointment and responsibilities**
The Trustees are responsible for preparing the report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
In the period covered by this report, no serious incidents were reported to the Charity Commission.
The law applicable to charities in England and Wales requires the Trustees to prepare financial statements for each financial year/period which give a true and fair view of the state of the affairs of the College, and the group, and of the incoming resources and application of resources of the group for that period. In preparing these financial statements, Trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgements and estimates that are reasonable and prudent;
- state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the College and enable them to ensure that the financial statements comply with the Charities Act 2022, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Royal Charter, the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended) and the provisions of the College’s Regulations. They are also responsible for safeguarding the assets of the College and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Trustees are responsible for the maintenance and integrity of the College and financial information included on the College’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
The Trustees confirm that, so far as they are aware, there is no relevant audit information of which the College’s auditor is unaware. They have taken all the steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the College’s auditor is aware of that information.
## **Training and induction of Trustees**
New Trustees are inducted into their role and College business through an induction programme which includes briefings from the CEO and key staff. As part of this process, information is provided about their roles and duties as charitable Trustees, as well as other supporting information about the governance of the College. There were four new Trustee appointments in 2025.
The CEO is appraised by the Chair on an annual basis.
26
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Remuneration**
The College recognises the importance of attracting and retaining the right skills to ensure it can deliver its objectives.
The RCOG operates a graded pay structure and all roles are subject to an evaluation process to determine the applicable pay grade.
The objectives of the evaluation process are as follows:
- To enable consistent decisions to be made on grading and rates of pay.
- To establish the extent to which there is comparable worth between jobs so that equal pay can be provided for work of equal value.
- To ensure staff are rewarded appropriately for the work they undertake for the College.
- To make sure all new posts are graded appropriately by ensuring a standard approach is taken when allocating grades.
The College operates an annual appraisal system to evaluate individual performance. This performance evaluation process enables an individual to move up their pay grade.
The Board governs the remuneration of staff via the **Nominations and Remuneration Committee** . The committee annually reviews all pay levels and, if affordable, recommends an annual uplift for Board approval.
Information on those employees paid over £60,000 in the year can be found in note 9 of the accounts. Trustees are not remunerated as these are voluntary roles.
## **Charity and related parties**
Related party transactions for the year are split as follows: sales ledger and purchase ledger. Further details can be found in note 11 to the accounts.
## **Principal risks and uncertainty**
The Audit and Risk Committee, as part of its duties, oversees risk management activity at the College. The committee has an assurance and oversight role to provide the Board of Trustees with the necessary assurance on the adequacy and effectiveness of the College’s risk management framework. Risk management is viewed as a dynamic cycle of assessment, action and review.
The Risk Management Policy outlines the approach to managing risk, setting out common requirements and definitions, and details specific responsibilities of staff, management and governance bodies. The risk management framework includes a Board Assurance Framework, which is monitored and updated by the Executive Directors and reported to the Audit and Risk Committee and the Board of Trustees on a quarterly basis. The Corporate Risk Register, which focuses on key operational risks, operates alongside this framework. The Register is regularly updated by the Senior Leadership Team and reviewed by Executive Directors, with higher level risks reported to Audit and Risk Committee at their quarterly meetings.
27
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
The most significant risks identified in the Board Assurance Framework are:
## **Quality: If the College fails to keep its education, training and standards current and responsive to regulatory and professional change then product quality, compliance and relevance may decline resulting in reduced membership and stakeholder confidence, competitiveness and income.**
The key controls for this risk are:
- Clear governance structure for education, training and guidance production through Education Board, Clinical Quality Board and relevant committees
- Defined review cycles and change control processes for curricula & educational resources
- Standardised guidance development methodology, including evidence appraisal frameworks and consistent use of structured processes
## **Reputation: If the College’s reputation, trust or credibility is damaged then RCOG membership and wider stakeholder confidence and support will reduce resulting in the College’s ability to deliver its charitable objectives being undermined.**
The key controls for this risk are:
- Code of Conduct in place for members and volunteers
- Staff induction and ongoing training on values, conduct and reputation
- Governance of public messaging through approved policy positions, structured communications planning, and formal sign-off of media and press outputs
- Complaints Policy and processes with regular review of complaints themes and learning
- Range of feedback channels for membership to report perception and satisfaction, including surveys, Council representatives, Committees and the Training Evaluation Form (TEF)
## **Business continuity (including cyber): If the College does not ensure adequate resilience, security, and investment in its IT and data systems then system failure or cyber-attack may occur resulting in disruption to critical services preventing effective support to staff, members, and trainees and delivery of the strategic aims.**
The key controls for this risk are:
- IT resilience arrangements including emergency shutdown and restart processes, backup power, live and test environments, and business continuity and incident response framework
- Cyber security controls including managed devices, mobile device management, real-time monitoring (SIEM), vulnerability testing, incident response arrangements, and staff training
- Technology governance and assurance through external testing, health checks, audits and regular review of security standards
- Planned replacement, upgrade and development of systems through a multi-year technology strategy and funded investment plan
28
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
- Cloud hosting and security controls implemented and governed in line with organisational standards, including resilience, access management and supplier assurance
## **Strategic: If the College lacks effective strategic oversight and horizon scanning then it may respond too slowly to external change resulting in the College’s ability to deliver its charitable objectives being undermined.**
The key controls for this risk are:
- Board approved five-year strategy and quarterly KPI reporting
- Quarterly review of Board Assurance Framework at Board and Audit and Risk Committee
## **Strategic: If the College fails to attract, retain and support sufficient volunteers then it will be unable to adequately resource and deliver core services resulting in the College’s ability to deliver its charitable objectives being undermined.**
The key controls for this risk are:
- People enabling goal and plan in place aligned to RCOG strategy 2025-30
- Inclusive recruitment practices embedded through dedicated careers site, recruitment system and established recruitment partners
- Use of benchmarking tools and partners to ensure our reward and benefits are competitive, fair and fit for purpose
- Learning and development programme incorporating leadership and management development, mandatory learning and all staff learning opportunities
- Employee engagement and internal communications to communicate RCOG’s employee offer internally and externally to enable two-way communication and listen to employee voice
## **Equality, Diversity and Inclusion**
The College has committed to building an inclusive and diverse workforce to ensure all employees can thrive, feel included, valued and reach their full potential whilst working with us.
As part of the EDI strategy, in 2025, the RCOG has prioritised four areas within an action plan:
1. A culture of inclusion, to ensure that as the College improves representation staff can thrive in a culture that is welcoming and understanding of difference, with practices in place that support inclusion.
2. Organisational performance and monitoring, basing action on data and ensuring progress is externally benchmarked.
3. Leadership and accountability, working with the College EDI Committee, and the Board, to ensure that the principles of equality, diversity and inclusion are embedded in the organisation.
4. Policies, practices and procedures, where actions will focus on reducing inequalities and barriers to inclusion by reviewing and making changes across the whole employee lifecycle, from recruitment through to talent development and exit from the College.
29
**Royal College of Obstetricians and Gynaecologists**
## **Trustees Annual Report**
## **For the year ended to 31 December 2025**
## **Nature of governing document**
The RCOG is governed by a Royal Charter, granted in 1947, and Regulations made pursuant to the Charter. The Charter was renewed in December 2003 and amended in 2012.
Updates to the RCOG’s Regulations were approved by the Board of Trustees in 2024.
In 2010, the College was separately registered as a charity in Scotland.
## **Public benefit**
The Board of Trustees confirm that they have considered the Charity Commission’s guidance on Public Benefit in determining the College’s five-year strategy for achieving the charity’s aims and objectives. The identifiable benefits women receive include the specialist clinical care made possible through the education of doctors. Women also benefit from service improvements through our focus on clinical quality, our participation in research and audit and our collaborative work with other educational providers, service bodies and policy makers in health. The number of doctors successfully qualifying in the specialty and the tangible use of our standards to improve care confirm that these benefits are being achieved. The general public and health professionals can access information via our website.
While the College is a professional and educational body, the ultimate beneficiaries of our work are women and their families in all the countries where our clinicians work and where the College delivers targeted help, including in lower-resourced regions.
## **Auditor**
## **In so far as the Trustees are aware:**
- there is no relevant audit information of which the charitable company's auditor is unaware; and
- the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.
A resolution proposing that Azets Audit Services be reappointed as auditor of the charitable company will be put to the members.
## **Consolidated accounts statement**
This annual report and accounts have been approved by the Trustees and are signed on their behalf by:
Baroness Tessa Blackstone Chair
30
**Independent auditor’s report**
## **To the Trustees of**
## **Royal College of Obstetricians and Gynaecologists**
## **Opinion**
We have audited the financial statements of Royal College of Obstetricians & Gynaecologists (the ‘parent charity’) for the year ended 31 December 2025, which comprise the consolidated statement of financial activities, the group and parent company balance sheets, the consolidated statement of cash flows and the notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements:
- Give a true and fair view of the state of the group and parent charity’s affairs as at 31 December 2025 and of the group’s incoming resources and application of resources, for the period then ended.
- Have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice.
- Have been prepared in accordance with the requirements of the Charities Act 2011 and of the Charities and Trustee Investment (Scotland) Act 2005 and regulations 6 and 8 of the Charities Accounts (Scotland) Regulations 2006 (as amended).
## **Basis for opinion**
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the group and charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
## **Conclusions relating to going concern**
In auditing the financial statements, we have concluded that the Trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.
## **Other information**
The other information comprises the information included in the Trustees Annual Report, other than the financial statements and our auditor’s report thereon. The Trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our
31
**Independent auditor’s report**
## **To the Trustees of**
## **Royal College of Obstetricians and Gynaecologists**
knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
## **Matters on which we are required to report by exception**
We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 and the Charities Accounts (Scotland) Regulations 2006 (as amended) require us to report to you if, in our opinion:
- The information given in the Trustees’ annual report is inconsistent in any material respect with the financial statements;
- Sufficient and proper accounting records have not been kept; or
- The financial statements are not in agreement with the accounting records and returns; or
- We have not received all the information and explanations we require for our audit **.**
## **Responsibilities of Trustees**
As explained more fully in the statement of Trustees’ responsibilities set out in the Trustees’ annual report, the Trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Trustees are responsible for assessing the group and parent charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the group or the parent charity to cease operations, or have no realistic alternative but to do so.
## **Auditor’s responsibilities for the audit of the financial statements**
We have been appointed as auditor under section 151 of the Charities Act 2011 and section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005 and report in accordance with regulations made under that Act.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
32
**Independent auditor’s report**
## **To the Trustees of**
## **Royal College of Obstetricians and Gynaecologists**
## **Extent to which the audit was considered capable of detecting irregularities, including fraud**
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.
We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.
In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:
- Enquiry of management and those charged with governance around actual and potential litigation and claims as well as actual, suspected and alleged fraud;
- Reviewing minutes of meetings of those charged with governance;
- Assessing the extent of compliance with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the company through enquiry and inspection;
- Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
- Performing audit work over the risk of management bias and override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for indicators of potential bias.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
33
**Independent auditor’s report**
## **To the Trustees of**
## **Royal College of Obstetricians and Gynaecologists**
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the charity’s internal control.
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the trustees.
- Conclude on the appropriateness of the trustees’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the charitable company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the charitable company to cease to continue as a going concern.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
## **Use of our report**
This report is made solely to the parent charity’s Trustees as a body, in accordance with section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005, section 144 of the Charities Act 2011 and regulations made under section 154 of that Act. Our audit work has been undertaken so that we might state to the parent charity’s Trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent charity and the parent charity’s Trustees as a body, for our audit work, for this report, or for the opinions we have formed.
Date: 8 July 2026 Azets Audit Services, Statutory Auditor First Floor, River House, 1 Maidstone Road, Sidcup, Kent, DA14 5RH
Azets Audit Services is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.
34
**Royal College of Obstetricians and Gynaecologists**
## **Consolidated statement of financial activities**
## **For the year ending 31 December 2025**
|Note
**Income from:**
Charitable activities
Donations and legacies
2
Charitable activities
3
Other trading activities
4
Investments
5
**Total income**
**Expenditure on:**
Charitable activities
Raising funds
6
Charitable activities
6
Other trading activities
6
**Total expenditure**
6
**Net income / (expenditure) before net gains /**
**(losses) on investments**
Net gains / (losses) on investments
16
**Net income / (expenditure)**
8
Transfers between funds
23-25
**Net income / (expenditure) before other**
**recognised gains and losses**
Actuarial gains / (losses) on defined benefit pension
schemes
27
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**
23-25|Unrestricted
£
127,267
18,563,275
1,502,183
148,948
20,341,673
423,133
19,051,117
535,560
20,009,810
331,863
333,908
665,771
12,798
678,569
-
678,569
50,618,949
51,297,518|Endowment
£
-
5,475
(6,360)
92,277
91,392
-
162,040
-
162,040
(70,648)
88,752
18,104
155,371
173,475
-
173,475
4,110,416
4,283,891|Restricted
£
605
898,759
-
100,856
1,000,220
-
1,122,769
-
1,122,769
(122,549)
33,576
(88,973)
(168,169)
(257,142)
-
(257,143)
5,789,093
5,531,951|**2025**
**Total**
**£**
**127,872**
**19,467,509**
**1,495,823**
**342,081**
**21,433,285**
**423,133**
**20,335,926**
**535,560**
**21,294,619**
**138,665**
**456,236**
**594,902**
**-**
**594,902**
**-**
**594,902**
**60,518,458**
**61,113,360**|Unrestricted
£
360,247
17,099,010
1,613,936
220,820
19,294,193
377,484
18,009,003
418,890
18,805,377
488,816
628,693
1,117,509
(56,732)
1,060,777
-
1,060,777
49,558,172
50,618,949|Endowment
£
98,903
-
-
45,317
144,220
-
67,390
-
67,390
76,830
133,550
210,380
(17,420)
192,960
-
192,960
3,917,456
4,110,416|Restricted
£
655
910,661
-
130,904
1,042,220
7,197
1,795,822
-
1,803,019
(760,799)
479,723
(281,076)
74,152)
(206,924)
-
(206,924)
5,996,017
5,789,093|**2024**
Total
£
**459,985**
**18,009,671**
**1,613,936**
**397,041**|
|---|---|---|---|---|---|---|---|---|
|||||||||**20,480,633**|
|||||||||**384,681**
**19,872,215**
**418,890**|
|||||||||**20,675,786**|
|||||||||**(195,153)**
**1,241,966**|
|||||||||**1,046,813**
-|
|||||||||**1,046,813**
-|
|||||||||**1,046,813**
59,471,645|
|||||||||60,518,458|
There were no other recognised gains or losses other than those stated above. Movements in funds are disclosed in Notes 23-25 to the financial statements.
35
**Royal College of Obstetricians and Gynaecologists**
## **Balance sheets (Company No. RC000792)**
## **As at 31 December 2025**
|Note
**Fixed assets:**
Intangible assets
13
Tangible assets
14
Investments
16
**Current assets:**
Stock
Debtors
19
Cash at bank and in hand
**Liabilities:**
Creditors: amounts falling due within one year
20
**Net current (liabilities)/assets**
**Net assets excluding pension asset**
Defined benefit pension scheme asset
27
**Total net assets**
**Funds:**
23
Capital funds:
Permanent endowment funds
Expendable endowment funds
23
Restricted income funds
24
Unrestricted income funds:
Designated funds
25
General funds
25
Total unrestricted funds
**Total funds**|**The group**
**2025**
2024
**£**
£
**1,197,436**
316,044
**42,065,818**
42,331,898
**17,880,891**
15,624,655
**61,144,145**
58,272,597
**73,336**
58,184
**3,089,752**
2,872,265
**979,678**
2,669,821
**4,142,766**
5,600,270
**(4,173,551)**
(3,354,409)
**(30,785)**
2,245,861
**61,113,360**
60,518,458
**-**
-
**61,113,360**
60,518,458
**472,899**
447,055
**3,810,992**
3,663,361
**4,283,891**
4,110,416
**5,531,951**
5,789,093
**43,457,119**
41,997,835
**7,840,399**
8,621,114
**51,297,518**
50,618,949
**61,113,360**
60,518,458|**The charity**
**2025**
2024
**£**
£
**1,197,436**
316,044
**42,065,818**
42,331,898
**17,880,893**
15,624,657
**61,144,147**
58,272,599
**73,336**
58,184
**3,027,068**
2,818,580
**979,678**
2,669,821
**4,080,082**
5,546,585
**(4,110,869)**
(3,300,726)
**(30,787)**
2,245,859
**61,113,360**
60,518,458
**-**
-
**61,113,3560**
60,518,458
**472,899**
447,055
**3,810,992**
3,663,361
**4,283,891**
4,110,416
**5,531,951**
5,789,093
**43,457,119**
41,997,835
**7,840,399**
8,621,114
**51,297,518**
50,618,949
**61,113,360**
60,518,458|**The charity**
**2025**
2024
**£**
£
**1,197,436**
316,044
**42,065,818**
42,331,898
**17,880,893**
15,624,657
**61,144,147**
58,272,599
**73,336**
58,184
**3,027,068**
2,818,580
**979,678**
2,669,821
**4,080,082**
5,546,585
**(4,110,869)**
(3,300,726)
**(30,787)**
2,245,859
**61,113,360**
60,518,458
**-**
-
**61,113,3560**
60,518,458
**472,899**
447,055
**3,810,992**
3,663,361
**4,283,891**
4,110,416
**5,531,951**
5,789,093
**43,457,119**
41,997,835
**7,840,399**
8,621,114
**51,297,518**
50,618,949
**61,113,360**
60,518,458|
|---|---|---|---|
||||58,272,599
58,184
2,818,580
2,669,821|
||||5,546,585
(3,300,726)|
||||2,245,859|
||||60,518,458
-|
||||60,518,458|
||||447,055
3,663,361|
||||4,110,416|
||||5,789,093|
||||41,997,835
8,621,114|
||||50,618,949|
||||60,518,458|
Approved by the board of management on 19 June 2026 and signed on their behalf by
Chair
Trustee
36
**Royal College of Obstetricians and Gynaecologists**
## **Consolidated statement of cash flows**
## **For the year ended 31 December 2025**
|**Reconciliation of net income / (expenditure) to net cash flow from operating activities**
**Net income for the reporting period**
**(as per the statement of financial activities)**
Depreciation & amortisation charges
Losses/(Gains) on investments
Dividends and interest from investments
(Increase)/decrease in stocks
(Increase)/decrease in debtors
(Decrease)/ increase in creditors
Loss on disposal of Fixed Assets
**Net cash provided by operating activities**
**Cash flows from investing activities:**
Dividends, interest and rents from investments
Purchase of fixed assets
Proceeds from sale of investments
Purchase of investments
**Net cash provided by / (used in) investing activities**
**Change in cash and cash equivalents in the period**
Cash and cash equivalents at the beginning of the period
**Cash and cash equivalents at the end of the period**|**2025**
**£**
**594,902**
**882,450**
**(456,236)**
**(342,081)**
**(15,151)**
**(217,487)**
**819,142**
**295**
**1,265,834**
**342,081**
**(1,498,059)**
**2,200,000**
**(4,000,000)**
**(2,955,976)**
**(1,690,142)**
**2,669,821**
**979,678**|2024
£
1,046,813
1,119,101
(1,241,966)
(397,041)
(23,233)
(1,259,522)
130,268
199|
|---|---|---|
|||(625,381)|
|||397,041
(541,765)
3,500,000
(4,910,903)|
|||(1,555,627)|
|||(2,181,008)
4,850,828|
|||2,669,821|
37
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **1 Accounting policies**
## **a) Statutory information**
The Royal College of Obstetricians and Gynaecologists is incorporated by Royal Charter as a charity registered with the Charity Commission in England & Wales and OSCR in Scotland. The registered office address is 10-18 Union Street, London, SE1 1SZ.
## **b) Basis of preparation**
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2011, the Companies Act 2006* and UK Generally Accepted Accounting Practice.
The financial statements are prepared on a going concern basis under the historical cost convention, modified to include certain items at fair value. The financial statements are prepared in sterling which is the functional currency of the charity.
These financial statements consolidate the results of the charity and its wholly owned subsidiary RCOG Trading Limited on a line-by-line basis. Transactions and balances between the charity and its subsidiary have been eliminated from the consolidated financial statements. Balances between the two companies are disclosed in the notes of the charity's balance sheet. A separate statement of financial activities, or income and expenditure account, for the charity itself is not presented as the summary of the result for the period is disclosed in the notes to the accounts.
The trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period.
## **c) Public benefit entity**
The charity meets the definition of a public benefit entity under FRS 102.
## **d) Going concern**
The year ended 31 December 2025 has seen the College return to normal trading following the extended impact of the coronavirus pandemic and associated government restrictions on operational delivery. Further detailed information on this assessment can be found in the Financial Review in the Report of the Trustees. The Trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern. The small net liabilities as at 31 December 2025 is due to clearing of planned investment drawdown to liquidity account.
## **e) Income recognition**
Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the income have been met, it is probable that the income will be received and that the amount can be measured reliably.
38
**Royal College of Obstetricians and Gynaecologists**
**Notes to the financial statements**
## **For the year ended 31 December 2025**
Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received, and the amount can be measured reliably and is not deferred. Income received in advance of the provision of a specified service is deferred until the criteria for income recognition are met.
## **Donations and legacies**
Donations and legacies are subset of non-exchange transactions that may have restrictions on use and, in the case of donation, may also have performance related conditions attached. In all cases, income is recognised at the point the charity is entitled to the funds.
## **Conferences, Congress and Meetings**
Conferences, Congress and meetings are stated gross of any expenditure or discounts in the financial statements. Monies receive in advance of the Conferences, Congress and meetings dates are posted to the balance sheet. Income is recognised on the Statement of Financial Activities on the events date.
## **Examinations**
Examinations income is stated gross of any expenditure which is not a discount or fee waiver and credited to the Statement of Financial Activities over the period of the examinations for each exam diet. Examination income for Part 1, Part 2 & DRCOG is administered by a third-party company, Pearson VUE. Payments received in advance of the related income being receivable are treated as deferred income within creditors.
## **Membership services**
Memberships and Subscriptions are accounted for on a receivable basis and credited to the statement of financial activities in the period to which they relate.
## **Clinical quality**
Clinical quality income arises from contracts and grants. All income received during the year is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met and it is probable that income will be received, and the amount can be measured reliably.
## **Education and training**
Education and training income arise from grants, journals, training fees, certification and e-learning platform. All income is recognised when the charity is entitled to the funds and performance conditions have been met where applicable.
## **Trading activities**
Trading activities are funds generated from building hires of spaces to commercial tenants and third parties for accommodation and venue hire and catering. All income is accounted for on receivable basis, gross of any expenditure.
39
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **f) Interest receivable**
- Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.
## **g) Fund accounting**
Restricted funds are to be used for specific purposes as laid down by the donor. Expenditure which meets these criteria is charged to the fund.
Endowment funds are split between permanent endowments and expendable endowments. The capital of the permanent endowments must be maintained, although the income can be utilised in accordance with the terms of the endowment. The total return approach is applied to 7 of the College’s permanent endowments. The policy is to treat the calculated present value of the original gift as the “core capital” that remains an endowment. The remaining value is the unapplied return and from this the College can set aside 5% each year for use on restricted projects. This represents the “applied return”.
Unrestricted funds are donations and other income received or generated for the charitable purposes.
Designated funds are unrestricted funds earmarked by the trustees for specific purposes.
## **h) Expenditure and irrecoverable VAT**
Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required, and the amount of the obligation can be measured reliably. Expenditure is classified under the following activity headings:
- Costs of raising funds relate to the costs incurred by the charity in inducing third parties to make voluntary contributions to it, as well as the cost of any activities with a fundraising purpose
- Expenditure on charitable activities includes the costs of delivering membership, examination, educational services undertaken to further the purposes of the charity and their associated support costs
Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.
40
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **i) Allocation of support costs & governance costs**
Resources expended are allocated to the particular activity where the cost relates directly to that activity. However, the cost of overall direction and administration of each activity, comprising the salary and overhead costs of the central function, is apportioned on the following basis which are an estimate, based on staff time, of the amount attributable to each activity.
|-|Conferences and meetings|7%|
|---|---|---|
|-|Raising Funds|1%|
|-|Examinations|9%|
|-|International initiatives|5%|
|-|Membership Services|32%|
|-|Clinical Quality|19%|
|-|Education and training|21%|
|-|Other trading activities|6%|
Where information about the aims, objectives and projects of the charity is provided to potential beneficiaries, the costs associated with this publicity are allocated to charitable expenditure.
Where such information about the aims, objectives and projects of the charity is also provided to potential donors, activity costs are apportioned between fundraising and charitable activities on the basis of area of literature occupied by each activity.
Governance costs are the costs associated with the governance arrangements of the charity. These costs are associated with constitutional and statutory requirements and include any costs associated with the strategic management of the charity’s activities.
## **j) Operating leases**
Rental charges are charged on a straight-line basis over the term of the lease.
## **k) Intangible assets – other**
Identifiable intangible assets are recorded at cost less accumulated amortisation and any provision for impairment. Internally generated intangible fixed assets, such as software, are recognised only if: an asset is created that can be identified, it is probable that the asset created will generate future economic benefits, and the development cost of the asset can be measured reliably.
Intangible assets are amortised on a straight-line basis over their useful lives. The useful lives of intangible assets are as follows:
Intangible Type Useful Life Reason Computer software 5 Years Deemed useful economic life
## **l) Tangible fixed assets**
Items of equipment are capitalised where the purchase price exceeds £10,000. Depreciation costs are allocated to activities on the basis of the use of the related assets in those activities. Assets are reviewed for impairment if circumstances indicate their carrying value may exceed their net realisable value and value in use.
Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is provided at rates calculated to write down the cost of each asset to its estimated residual value over its expected useful life. The depreciation rates in use are as follows:
41
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
**For the year ended 31 December 2025**
|**he**|**year ended 31 December 2025**||
|---|---|---|
|-|Freehold land|not depreciated|
|-|Component parts of Freehold buildings|between 15-75 years|
|-|Plant|10 years|
|-|Furniture and fittings & IT infrastructure|5 years|
|-|Computer Equipment|3 years|
## **m) Listed investments**
Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price. Any change in fair value will be recognised in the statement of financial activities. Investment gains and losses, whether realised or unrealised, are combined and shown in the heading “Net gains/(losses) on investments” in the statement of financial activities. The charity does not acquire put options, derivatives or other complex financial instruments.
## **n) Investments in subsidiaries**
Investments in subsidiaries are at cost.
## **o) Stocks**
Stocks are stated at the lower of cost and net realisable value. In general, cost is determined on a first in first out basis and includes transport and handling costs. Net realisable value is the price at which stocks can be sold in the normal course of business after allowing for the costs of realisation. Provision is made where necessary for obsolete, slow moving and defective stocks.
## **p) Debtors**
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. Debtors due in greater than one year have been discounted to net present value.
## **q) Cash at bank and in hand**
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
## **r) Creditors and provisions**
Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amoun after allowing for any trade discounts due.
## **s) Financial instruments**
The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
## **t)**
## **Pensions**
The defined benefit pension scheme is recognised and treated in accordance with section 28 of FRS 102.
The defined benefit pension scheme assets are measured using market values. The scheme's liabilities are measured using the projected units actuarial method and are discounted at the current rate of return on a high-quality corporate bond of equivalent term and currency to the liability. The current service cost and any increase in the present value of the liabilities within the College's defined benefit scheme expected to arise
42
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
from employee service in the period is allocated to the respective expenses category (as outlined above) in respect to staff costs.
Actuarial gains and losses, in respect of the College's defined benefit scheme are recognised in the Statement of Financial Activities in recognised gains and losses for the period.
Contributions in respect of the College's defined benefit scheme are recognised in the Statement of Financial Activities in recognised gains and losses for the period.
The College also operates a defined contribution scheme. The assets of this scheme are held separately from those of the College in an independently administered fund. The pension cost charge represents contributions payable under the scheme by the College to the fund. The College has no liability under this scheme other than for the payment of those contributions.
## **u) Tax**
The charity is an exempt charity within the meaning of schedule 3 of the Charities Act 2011 and is considered to pass the tests set out in Paragraph 1 Schedule 6 Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes.
## **v) Judgements and key sources of estimation uncertainty’**
Accounting estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The College makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.
## _Useful economic lives of tangible assets_
The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are reassessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See note 14 for the carrying amount of the property plant and equipment and note 1(k) and 1(l) for the useful economic lives for each class of assets.
## _LGPS_
The present value of the defined benefit liability depends on a number of factors that are determined on an actuarial basis using a variety of assumptions. The assumptions used in determining the net cost (income) for pensions include the discount rate. Any changes in these assumptions, which are disclosed in note 27, will impact the carrying amount of the pension liability. Furthermore, a roll forward approach which projects results from the latest full actuarial valuation performed at 1 April 2024 has been used by the actuary in valuing the pensions liability at 31 December 2025. Any differences between the figures derived from the roll forward approach and a full actuarial valuation would impact on the carrying amount of the pension liability.
43
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
- **2 Income from donations and legacies**
|Unrestricted
Endowment
Restricted
£
£
£
Gifts & Donations
102
-
605
Legacies
127,165
-
-
127,267
-
605
Gifts & donations represent income from fundraising activities.
**3**
**Income from charitable activities**
Unrestricted
Endowment
Restricted
£
£
£
Conferences,
Congress and
meetings
3,329,262
5,475
-
Examinations
6,889,858
-
-
Membership
services
6,043,261
-
-
Clinical quality
1,251,324
-
898,759
Education and
training initiatives
1,049,570
-
-
18,563,275
5,475
898,759|Unrestricted
Endowment
Restricted
£
£
£
Gifts & Donations
102
-
605
Legacies
127,165
-
-
127,267
-
605
Gifts & donations represent income from fundraising activities.
**3**
**Income from charitable activities**
Unrestricted
Endowment
Restricted
£
£
£
Conferences,
Congress and
meetings
3,329,262
5,475
-
Examinations
6,889,858
-
-
Membership
services
6,043,261
-
-
Clinical quality
1,251,324
-
898,759
Education and
training initiatives
1,049,570
-
-
18,563,275
5,475
898,759||**2025**
**Total**
**£**
**707**
**127,165**
**127,872**
**2025**
**Total**
**£**
**3,334,737**
**6,889,858**
**6,043,261**
**2,150,083**
**1,049,570**||Unrestricted
£
110,427
250,000
360,427
Unrestricted
£
2,157,313
6,434,736
5,684,482
1,794,422
1,028,057
17,099,010|Endowment
£
98,903
-|Restricted
£
655
-
655
Restricted
£
40,879
-
8,136
861,646
-
910,661|Restricted
£
655
-||**2024**
Total
£
209,985
250,000
459,985
2024
Total
£
2,198,192
6,434,736
5,692,618
2,656,068
1,028,057|
|---|---|---|---|---|---|---|---|---|---|---|
|||||||98,903||655|||
|||||||Endowment
£
-
-
-
-
-
-|||||
||898,759||**19,467,509**|||||||18,009,671|
|**4**
**Income from other trading activities**
Unrestricted
Endowment
£
£
680,245
-
Venue hire and catering
724,416
-
Accommodation and
service charges
97,522
(6,360)
1,502,183
(6,360)
**5**
**Income from investments**
Unrestricted
Endowment
£
£
BIJF Dynamic
Diversified Growth
Fund
102,316
92,277
Sarasins
46,632
-
148,948
92,277|Restricted
£
-
-
-
-
Restricted
£
100,856
-
100,856||**2025**
**Total**
**£**
**680,245**
**724,416**
**91,162**
**1,495,823**
**2025**
**Total**
**£**
**295,449**
**46,632**
**342,081**|Unrestricted
£
750,039
558,042
305,855
1,613,936
Unrestricted
£
123,053
97,767
220,820|Endowment
£
-
-
-
-
Endowment
£
45,317
-
45,317|Restricted
£
-
-
-
-
Restricted
£
130,904
-
130,904||2024
Total
Restated
£
750,039
558,042
305,855|
|---|---|---|---|---|---|---|---|---|
|||||||||1,613,936|
|||||||||2024
Total
£
299,274
97,767|
|||||||||397,041|
44
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
|**6a**
**Analysis of expenditure (current year)**
Cost of
raising
funds
£
Staff costs (Note 9)
198,383
Direct costs
35,566
Direct costs: International Cost
-
Support costs:
Officers, Council and Administration
-
Finance and professional costs
-
Facilities and Premises
-
Other:
-
Depreciation & Loss On Disposal
-
Amortisation
Human resources
-
Other
-
233,949
Support costs
168,327
Governance costs
20,857
**Total expenditure 2025**
**423,133**|**6a**
**Analysis of expenditure (current year)**
Cost of
raising
funds
£
Staff costs (Note 9)
198,383
Direct costs
35,566
Direct costs: International Cost
-
Support costs:
Officers, Council and Administration
-
Finance and professional costs
-
Facilities and Premises
-
Other:
-
Depreciation & Loss On Disposal
-
Amortisation
Human resources
-
Other
-
233,949
Support costs
168,327
Governance costs
20,857
**Total expenditure 2025**
**423,133**|Charitable activities
Conferences,
Congress
and
Meetings
Examinations
International
initiatives
Membership
services
Clinical
Quality
Education
and
Training
Initiatives
Other
restricted
funds
Other
trading
activities
Governance
costs
Support
costs
**2025**
**2024**
£
£
£
£
£
£
£
£
£
£
**£**
£
496,164
571,122
138,856
2,341,453
1,020,732
1,236,396
508,486
-
514,402
3,078,630
**10,104,624**
10,134,064
2,314,502
2,513,336
13,723
470,893
606,053
434,667
577,964
-
378,413
-
**7,345,117**
6,801,047
-
-
-
-
-
-
-
-
-
-
**-**
689,705
**-**
-
-
-
-
-
-
-
-
-
-
35,785
**35,785**
39,199
-
-
-
-
-
-
-
-
-
1,086,336
**1,086,336**
792,357
-
-
-
-
-
-
-
-
-
1,222,222
**1,222,222**
783,315
-
-
-
-
-
-
-
-
-
-
**-**
**-**
-
-
-
-
-
-
56,190
-
-
648,793
**704,983**
918,835
142,169
35,594
**177,763**
-
-
-
-
-
-
-
-
-
-
204,925
**204,925**
142,536
-
-
-
-
-
-
-
-
-
412,864
**412,864**
374,727|
|---|---|---|
||233,949
168,327
20,857|2,810,666
3,084,458
152,579
2,812,346
1,626,785
1,671,063
1,284,809
-
892,815
6,725,149
21,294,619
20,675,786
297,984
637,738
223,829
2,403,215
1,081,842
1,435,699
-
476,515
-
(6,725,149)
**-**
-
36,923
108,774
27,735
297,781
134,051
207,649
-
59,045
(892,815)
-
**-**
-|
||**423,133**|**3,145,573**
**3,830,970**
**404,143**
**5,513,342**
**2,842,678**
**3,314,411**
**1,284,809**
**535,560**
**-**
**-**
**21,294,619**
**20,675,786**|
Cost of raising funds comprises 100% of business development department pay & non pay costs, plus an allocation of the total pay & non-pay costs for departments that support general day to day business operations, again weighted for the FTE in the business development department.
Support costs comprises 100% of pay and non-pay costs for departments that support general day to day operations. These are finance, buildings, Chief Executive, IT & People. Governance costs comprises 100% of the pay and non-pay costs of the governance departments plus general non pay costs.
## 6b **Governance Costs**
|Staff Costs
Trustee Expenses
Consultancy
External auditor's remuneration (including expenses & benefits in kind)
Internal audit
Legal fees
Support Costs
Support costs|**2025**
2024
**£**
£
**514,402**
504,665
**3,531**
1,656
**5,950**
113
**52,943**
51,650
**8,389**
15,692
**71,661**
124,270
**235,939**
151,403|
|---|---|
||**892,815**
849,449|
45
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **6b Analysis of expenditure (prior year)**
|||||Charitable activities|Charitable activities||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||Education||||||
||Cost of|Conferences,|||||and|Other|Other||||
||raising|Congress and||International|Membership|Clinical|Training|restricted|trading|Governance|||
||funds|Meetings|Examinations|initiatives|services|Quality|Initiatives|funds|activities|costs|Support costs|**2024**|
||£|£|£|£|£|£|£|£|£|£|£|**£**|
|Staff costs (Note 9)|225,737|483,860|582,219|120,425|2,263,104|1,144,871|1,295,016|725,009|-|504,666|2,789,157|**10,134,064**|
|Direct costs|51,046|958,502|2,276,411|2,705|475,522|1,125,540|421,238|1,145,400|-|344,783|-|**6,801,047**|
|Support costs:|-|-|-|-|-|-|-|-|-|-|-|**689,705**|
|Officers, Council and Administration|-|-|-|-|-|-|-|-|-|-|39,199|**39,199**|
|Finance|-|-|-|-|-|-|-|-|-|-|792,357|**792,357**|
|Facilities and Premises|-|-|-|-|-|-|-|-|-|-|783,316|**783,316**|
|Other:|-|-|-|-|-|-|-|-|-|-|-|-|
|Depreciation|||||||||||918,835|**918,835**|
|Human resources|||||||||||142,536|**142,536**|
|Other|-|-|-|-|-|-|-|-|-|-|374,727|**374,727**|
||276,783|1,442,362|3,584,335|123,120|2,738,626|2,270,311|1,716,254|1,870,409|-|849,449|5,840,127|20,675,786|
|Support costs|94,197|432,550|556,334|257,431|1,976,387|944,016|1,213,513|-|365,699|-|(5,840,127)|**-**|
|Governance costs|13,701|62,915|80,919|37,443|287,466|137,707|176,507|-|53,191|(849,449)|-|**-**|
|**Total expenditure 2024**|**384,681**|**1,932,827**|**4,185,588**|**418,044**|**5,002,479**|**3,351,634**|**3,109,274**|**1,870,409**|**418,890**|**-**|**-**|**20,675,786**|
46
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **7 Direct costs comprise:**
## **Conferences and meetings**
Includes venue and catering costs, course materials and Congress expenditure.
## **Examinations**
Costs incurred for the development, delivery and quality assurance of the MRCOG & DRCOG examinations.
## **International initiatives**
Costs associated with the delivery of international projects; expenditure associated with
International Liaison groups and the International Executive committee.
## **Fellows and Members**
Includes costs of member services; journals & e-publishing; eLearning resources expenditure; media and policy expenditure.
## **Clinical quality**
Includes costs of producing guidelines and patient information; expenditure on externally funded projects.
## **Education and training**
Costs incurred for the development and ongoing review of curricula, training and educational resources.
## **Other restricted funds**
Costs incurred in the delivery of restricted activity.
|**8**
**Net income / (expenditure) for the period**
This is stated after charging:
Depreciation and Amortisation
Auditors' remuneration (excluding VAT):
Audit (college)
Audit (subsidiary)
Other services
**9**
**Analysis of staff costs, trustee remuneration and expenses, and the cost of key management personnel**
Staff costs were as follows:
Salaries and wages
Redundancy costs
Social security costs
Employer’s contribution to College pension schemes
Salaries - 3rd Party
Agency Staff|**2025**
**£**
**882,450**
**41,350**
**8,530**
**-**
**2025**
**£**
**7,912,227**
**38,953**
**1,074,742**
**616,203**
**385,861**
**76,638**
**10,104,624**|**2024**
£
1,119,101
37,000
8,000
5,000
**2024**
£
8,096,997
9,016
928,165
597,013
465,197
37,676|
|---|---|---|
|||10,134,064|
|The following number of employees received employee benefits (excluding employer pension costs) during the period between:|The following number of employees received employee benefits (excluding employer pension costs) during the period between:||
|---|---|---|
||**2025**|**2024**|
||**No.**|No.|
|£60,001-£70,000|**22**|16|
|£70,001-£80,000|**6**|7|
|£80,001-£90,000|**8**|5|
|£90,001-£110,000|**-**|3|
|£110,001-£120,000|**3**|1|
|£120,001-£130,000|**1**|-|
|£130,001-£180,000|**-**|1|
|£180,001-£200,000|**1**|-|
Redundancy costs of £38,953 (2024: £9,016) were paid during the year and related to compensation for loss of office.
47
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
The total employee benefits (including pension contributions and employer's national insurance) of the key management personnel were £799,327 (2024: £742,580).
The Trustees were not paid or received any other benefits from employment with the charity in the period (2024: £nil). No member of the board of management received payment for professional or other services supplied to the charity (2024: £nil).
Trustees expenses represents the payment or reimbursement of travel, accommodation and subsistence costs totalling £11,080 (2024: £8,408) incurred by 9 (2024: 6) members relating to attendance at meetings of the trustees, ceremonies, events & international exam sittings.
## **10 Staff numbers**
The average number of employees (head count based on number of staff employed) during the year was as follows:
|Raising funds
Conferences & Meetings
Examinations
International Initiative
Membership services
Clinical Quality
Education and training initiatives
Support|**2025**
**No.**
**4**
**10**
**11**
**2**
**31**
**25**
**20**
**73**
**176**|2024
No.
4
10
12
4
35
25
20
73|
|---|---|---|
|||183|
48
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **11 Related party transactions**
Related party transactions for the financial year were split between sales and purchase ledger transactions. These were payments to Council members as follows; J Plumb £10,000 (2024: £10,000) honorarium as the lead for Women's Voices on the Women's Network and £34 (2024: £75) for consultancy services; F El Baz and E Crookes £3,000 (2024: £3,000) & £3,600 (2024: £3,000) respectively as Vice Chair of the Women's Network. E Crookes was also paid £820 (2024: £1,318) for consultancy services and exam review services. Abigail Hyland, Hans Nagar and Phillip Rolland were all given council allowances for Congress 2025 of £500 each (2024: nil). Sherif AbdelFattah & Ganga Verma were given council allowances for Congress 2025 of £447 (2024: nil) & £465.65 (2024: nil) respectively. There was also reimbursement of costs for travel, accommodation and subsistence for J Plumb £788 (2024: nil), F El Baz £116 (2024: nil), A Hyland £574 (2024: nil), H Nagar £86 (2024:nil), P Rolland £214 (2024:nil) & S Abdel Fattah £2,404 (2024:nil). FIGO also invoiced RCOG for £27,775 (2024: £25,975) for membership fees during the year. RCOG also recharged FIGO £343,266 (2024: £323,731) during the year for life assurance and payroll costs. RCOG is one of the national member society representatives on FIGO Council.
## **12 Taxation**
The charity is exempt from corporation tax as all its income is charitable and is applied for charitable purposes. The charity's trading subsidiary RCOG Limited gift aids available profits to the parent charity.
## **13 Intangible fixed Assets**
|**For the group and charity**
**Cost**
At the start of the year
Additions in year
Transfer from Plant, furniture and equipment
At the end of the year
**Amortisation**
At the start of the year
Charge for the year
At the end of the year
**Net book value**
**At the end of the year**
At the start of the year|Computer
Software
1,442,807
644,778
414,376
2,501,961
1,126,763
177,762
1,304,525
1,197,436
316,044|**Total**
**£**
**1,857,183**
**644,778**
**414,376**|
|---|---|---|
|||**2,501,961**|
|||**1,126,763**
**177,762**
**1,304,525**|
|||**1,197,436**|
|||316,044|
The transfer from plant, furniture and equipment of £414,376 includes the new Customer Relationship Management system that college is implementing.
49
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **14 Tangible fixed Assets**
|**Tangible fixed Assets**|||||
|---|---|---|---|---|
|**For the group and charity**
**Cost**
At the start of the year
Additions in year
Disposals in year
Transfer to Intangible assets
At the end of the year
**Depreciation**
At the start of the year
Charge for the year
Eliminated on disposal
At the end of the year
**Net book value**
**At the end of the year**
At the start of the year|Freehold Land
and Buildings
£
43,426,328
617,125
-
-
44,043,453
2,235,632
512,090
-
2,747,722
41,295,731
41,190,696|Plant,
furniture
and
equipment
£
2,547,260
236,154
(53,420)
(414,376)
2,315,618
1,706,058
192,598
(53,125)
1,854,531
470,086
841,202|Heritage
assets
£
300,000
-
-
-
300,000
-
-
-
-
300,000
300,000|**Total**
**£**
**45,859,212**
**853,279**
**(53,420)**
**(414,376)**|
|||||**46,659,071**|
|||||**3,941,690**
**704,688**
**(53,125)**|
|||||**4,593,253**|
|||||**42,065,818**|
|||||42,331,898|
Freehold land and buildings comprise the land in Union Street valued at £18.5m and the building valued at £24.8m, the component parts of the latter being depreciated over periods ranging from 15 to 75 years.
10-18 Union Street is used as the primary operational office for the College, but part of the office space is leased to another organisation. The facilities are also available for external hire. However, as the commercial space available changes over time and cannot be separately valued, the whole property is treated as a fixed asset.
## **15 Heritage Assets**
A separate category of donated assets are those historic assets which the College holds for their heritage, scientific importance, and contribution to the educational advancement in women's health. These items hold an intrinsic value to the business of the College.
The Heritage items mainly include books, sculptured busts and portraits of past Presidents and instruments used in the historic application and study of Obstetricians and Gynaecologists. Many of the portraits remain on display around the College and a small sample of the instruments held form part of the display in the College museum. The remaining collections are held in appropriate environmentally controlled conditions on the premises.
The College maintains a central electronic catalogue of Heritage items which is reviewed and updated at least annually by the Operations Director and Archivist & Records Manager.
Trustees do not believe that a reasonable valuation can be placed on those donated assets which are held as heritage assets, and which have not been capitalised.
Expenditure which, in the Trustees view, is required to preserve or clearly prevent further deterioration of individual collection items is recognised in the statement of financial activities when incurred.
Because of the uniqueness, substance, and direct affiliation of these heritage assets with the College, conventional market valuation would lack the true value imparted and comparisons on which to base this value are unlikely to be reflected in the open market. As a result, these items are not recognised in the balance sheet of the College.
50
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
- **16 Listed investments (group and charity)**
|**Consolidated**
Fair value at the start of the year
Additions at cost
Disposal proceeds
Net gain / (loss) on change in fair value
Fair value at the end of the year
Historic cost at the end of the year
Investments comprise:
UK based unit trusts
UK based equity funds
Cash awaiting re-investment
Share Capital held for RCOGT|**2025**
**£**
**15,624,655**
**4,000,000**
**(2,200,000)**
**456,236**
**17,880,891**
**17,880,891**
**15,549,288**
**2025**
**£**
**12,849,195**
**5,001,382**
**30,314**
**17,880,891**
**2**
**17,880,893**|2024
£
12,971,786
4,910,903
(3,500,000)
1,241,966|
|---|---|---|
|||15,625,655|
|||15,624,655|
|||13,671,830|
|||2024
£
12,633,594
2,980,989
10,072|
|||15,624,655
2|
|||15,624,657|
## **17 Subsidiary undertaking**
The College owns 100% of RCOG Trading Limited (Company no: 04495641), whose main activities include the hire of facilities owned by the Royal College of Obstetricians and Gynaecologists and the provision of catering. It donates its taxable profits to the College under gift aid. Trading results extracted from its audited financial statements are shown below:
|Turnover
Cost of sales
Gross profit
Administrative expenses
Management charge due to parent undertaking
Operating profit / (loss)
Interest payable
Profit / (loss) on ordinary activities
Deed of covenant to parent undertaking
Profit / (loss) for the financial year
The aggregate of the assets, liabilities and funds was:
Assets
Liabilities
Funds|**2025**
**£**
**699,525**
**(69,984)**
**629,541**
(11,214)
(151,326)
**467,001**
**-**
**467,001**
**(467,001)**
**-**
**224,646**
**(224,644)**
**2**|**2024**
£
769,716
(15,706)|
|---|---|---|
|||754,010
(17,834)
(146,953)|
|||589,223
**-**|
|||589,223
**(589,223)**|
|||-|
|||268,104
(268,102)|
|||**2**|
- **18 Parent charity**
The parent charity's gross income and the results for the year are disclosed as follows:
|Gross income
Result for the year|**2025**
**£**
**20,733,760**
594,901|**2024**
£
19,710,917
1,046,813|
|---|---|---|
51
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **19 Debtors**
|Trade debtors
Amount owed by the subsidiary
Accrued Income
Prepayments
Other debtors|**The gro**
**2025**
**£**
**1,011,492**
**-**
**1,122,740**
**390,336**
**565,184**
**3,089,752**|**up**
2024
£
1,524,088
-
925,913
404,635
17,629
2,872,265|**The charity**
**2025**
2024
**£**
£
**786,846**
1,255,985
**161,962**
214,418
**1,122,740**
925,913
**390,336**
404,635
**565,184**
17,629
**3,027,068**
2,818,580|
|---|---|---|---|
With the exception of listed investments and debtors due in more than one year all of the charity’s financial instruments, both assets and liabilities, are measured at amortised cost.
## **20 Creditors: amounts falling due within one year**
|Trade creditors
Taxation and social security
Accruals
Deferred income
Other Creditor|**The gro**
**2025**
**£**
**1,553,766**
**797,900**
**1,086,815**
**717,780**
**17,829**
**4,173,551**|**up**
2024
£
506,132
710,831
1,468,742
664,024
4,680
3,354,409|**The charity**
**2025**
2024
**£**
£
**1,553,766**
506,132
**744,798**
666,148
**1,077,235**
1,459,742
**717,780**
664,024
**17,829**
4680
**4,110,869**
3,300,726|**The charity**
**2025**
2024
**£**
£
**1,553,766**
506,132
**744,798**
666,148
**1,077,235**
1,459,742
**717,780**
664,024
**17,829**
4680
**4,110,869**
3,300,726|
|---|---|---|---|---|
|||||3,300,726|
## **21 Deferred income**
Deferred income comprises membership, exam and delegate fees which relate to year ended 31 December 2025
|Balance at the beginning of the period
Amount released to income in the period
Amount deferred in the period
Balance at the end of the period|**The gro**
**2025**
**£**
**664,024**
**(664,024)**
**717,780**
**717,780**|**up**
2024
£
745,588
(745,588)
664,024
664,024|**The charity**
**2025**
2024
**£**
£
**664,024**
730,588
**(664,024)**
(730,588)
**717,780**
664,024
**717,780**
664,024|**The charity**
**2025**
2024
**£**
£
**664,024**
730,588
**(664,024)**
(730,588)
**717,780**
664,024
**717,780**
664,024|
|---|---|---|---|---|
|||||664,024|
Deferred income largely comprises deferred membership relating to the next financial year, events booking in advance and contractual income in advance.
**22 Analysis of group net assets between funds (current period)**
|Tangible fixed assets
Intangible fixed assets
Investments
Net current liabilities
Net assets at the end of the period|General
Unrestricted
£
-
-
12,863,083
(5,022,684)
**7,840,399**|Designated
£
39,584,414
1,064,849
-
2,807,856
**43,457,119**|Endowment
£
-
-
4,283,891
-
**4,283,891**|Restricted
£
2,481,404
132,587
733,916
2,184,044
**5,531,951**|**Total funds**
**£**
**42,065,818**
**1,197,436**
**17,880,891**
**(30,785)**|
|---|---|---|---|---|---|
||||||**61,113,360**|
52
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
|**23a**
**Movements in funds - permanent endowments (current period)**
**Permanent Endowments**
Thomas Watts Eden Fellowship
Tim Chard Prize Fund
Edwards & Steptoe Trust
**Expendable Endowments**
President's Fund
Edgar Research - Jean Ethel Gentili Scholarship
Sims Black Travelling Professors Fund
Green Armytage and Spackman Travelling Scholarship Fund
Green Armytage Anglo American
Florence Blair-Bell Art Fund
William Blair-Bell Memorial
Victor Bonney Prize Fund
James Wyatt Dining Fund
JY Simpson Oration
William Meredith Fletcher Shaw
Sir Eardley Holland Medal fund
Ethicon Foundation Fund
Lindsay Stewart Fund
General Scholarship
Works Of Art
General Lectureship
General Purpose
General Research
**Total endowment funds**|At 1 January 2025
£
312,622
35,490
98,903
447,055
322,086
698,400
534,268
44,073
32,262
23,318
31,024
29,578
16,409
3,380
14,670
5,727
160,512
45,676
551,826
30,040
32,058
691,483
396,201
3,663,361
4,110,416|Income
£
5,567
750
1,621
7,938
4,907
15,484
12,139
1,034
749
540
718
684
380
78
339
133
3,706
999
13,200
579
1,024
17,773
8,988
83,454
91,392|Expenditure
£
-
(200)
-
(200)
(119,810)
(29,167)
(9,636)
-
-
-
-
-
-
-
-
-
-
(2,500)
12,000
(5,000)
-
-
(7,727)
(161,840)
(162,040)|Gains & Losses
4,595
619
13,941
19,155
4,780
12,777
10,017
854
618
445
592
565
313
65
280
109
3,058
824
10,894
478
845
14,666
7,417
69,598
88,752|Transfers
£
-
6,751
(7,800)
(1,049)
49,087
-
-
-
-
-
-
-
-
-
-
-
-
-
18,696
-
12,182
76,455
-
156,420
155,371|**At 31 December 2025**
**£**
**322,824**
**43,410**
**106,665**|
|---|---|---|---|---|---|---|
|||||||**472,899**|
|||||||**261,050**
**697,494**
**546,788**
**46,591**
**33,729**
**24,303**
**32,334**
**30,827**
**17,102**
**3,523**
**15,289**
**5,969**
**166,916**
**44,999**
**606,616**
**26,097**
**46,109**
**800,377**
**404,879**|
|||||||**3,810,992**|
|||||||**4,283,891**|
53
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
|**23b**
**Movements in funds - permanent endowments (prior year)**
**Permanent Endowments**
Thomas Watts Eden Fellowship
Tim Chard Prize Fund
Edwards & Steptoe Trust
**Expendable Endowments**
President's Fund
Edgar Research - Jean Ethel Gentili Scholarship
Florence and William Blair Bell
Sims Black Travelling Professors Fund
Green Armytage and Spackman Travelling
Scholarship Fund
Green Armytage Anglo American
Florence Blair-Bell Art Fund
William Blair-Bell Memorial
Victor Bonney Prize Fund
James Wyatt Dining Fund
JY Simpson Oration
William Meredith Fletcher Shaw
Sir Eardley Holland Medal fund
Ethicon Foundation Fund
Lindsay Stewart Fund
General Scholarship
Works Of Art
General Lectureship
General Purpose
General Research
**Total endowment funds**|At 1 January 2024
£
285,968
32,427
-
318,395
309,299
670,672
3,061
586,996
42,928
31,077
22,392
29,792
28,403
15,758
3,246
14,088
5,500
153,794
46,263
529,918
25,786
30,785
664,030
385,273
3,599,061
3,917,456|Income
£
-
-
98,903
98,903
3,894
8,445
39
7,391
541
391
282
375
358
198
41
177
69
1,936
583
6,672
325
388
8,361
4,851
45,317
144,220|Expenditure
£
(314)
-
-
(314)
-
-
-
(59,576)
-
-
-
-
-
-
-
-
-
-
(2,500)
-
-
-
-
(5,000)
(67,076)
(67,390)|Gains & Losses
27,008
3,063
-
30,071
8,893
19,283
88
16,877
1,234
894
644
857
817
453
93
405
158
4,422
1,330
15,236
741
885
19,092
11,077
103,749
133,550|Transfers
£
-
-
-
-
-
-
-
(17,420)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
(17,420)
(17,420)|**At 31 December**
**2024**
**£**
**312,662**
**35,490**
**98,903**|
|---|---|---|---|---|---|---|
|||||||**447,055**|
|||||||**322,086**
**698,400**
**3,188**
**534,268**
**44,703**
**32,362**
**23,318**
**31,024**
**29,578**
**16,409**
**3,380**
**14,670**
**5,727**
**160,152**
**45,676**
**551,826**
**26,852**
**32,058**
**691,483**
**396,201**|
|||||||3,663,361|
|||||||**4,110,416**|
54
**Royal College of Obstetricians and Gynaecologists**
**Notes to the financial statements**
## **For the year ended 31 December 2025**
## **23 Movements in funds - permanent endowments (continued)**
## **Purposes of permanent endowments:**
## **Thomas Watts Eden Fellowship**
For the provision of travelling expenses of medical graduates of not less than two years standing to any approved UK or Commonwealth University for participation in a research project.
## **Tim Chard Prize fund**
To fund the Tim Chard Case History Prize endowed by St Bartholomew Hospital Trust and the Royal London School of Medicine and Dentistry to mark the late Professor Tim Chard’s contribution to 3q3 Obstetrics and Gynaecology.
## **Edwards & Steptoe Trust**
The purpose of this fund is to fund a fertility stream in the UK congress in one year and produce a young person lecture for the same subject.
## **Purposes of expendable endowments:**
## **Edgar Research - Jean Ethel Gentilli Scholarship**
For the purpose of education and or research in obstetrics and or gynaecology. The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Scholarship.
## **Florence and William Blair-Bell Memorial Fund**
To fund fellowships with the object of bridging the widening gap between scientific research and clinical practice.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as RCOG Premises.
## **Sims Black Travelling Fund**
For the provision of travel awards to lecture, teach or engage in research in Obstetrics or Gynaecology.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as Travel.
## **Green Armytage and Spackman Travelling Scholarship Fund**
To fund a scholarship to encourage the study and to advance the science and art of obstetrics and gynaecology.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Scholarship.
## **Green Armytage Anglo American**
To award a lectureship biennially, alternately between a British and an American lecturer.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Lectureship.
55
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **Florence Blair-Bell Art Fund**
To purchase antique furniture, ornaments, pictures, and books printed before 1937.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as Works of Art.
## **William Blair-Bell Memorial**
To pay honorariums and contribute to travelling expenses for two lectures.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Lectureship
## **Victor Bonney Prize Fund**
To pay honorariums and contribute to travelling expenses for two lectures.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Scholarship
## **James Wyatt Dining Fund**
To provide a dinner for the Council every two years.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Purpose
## **JY Simpson Oration Fund**
To fund the delivery of an annual lecture.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Lectureship
## **William Meredith Fletcher Shaw Memorial Lectureship**
For awarding a lectureship to a senior Fellow of the College.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Lectureship
## **Sir Eardley Holland Medal Fund**
For awarding a gold medal once every five years for outstanding original work.
The Charity Commission have approved the release of the permanent endowment, this is now included within expendable endowments, with a future purpose deemed as General Purpose.
## **President's Fund**
To fund exceptional items of expenditure at the President's discretion.
## **President’s Global Health Fund**
The fund is to be used to prime the initiation of the RCOG International fundraising strategy.
## **Ethicon Foundation Fund**
For the provision of travel awards to enable members to attend postgraduate training courses, centres for research and similar.
## **Lindsay Stewart Research and Development Fund**
To support the ongoing and future health service research activities of the College.
56
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
|**24a**
**Movements in funds - restricted funds (current period)**
**Scholarship and lecture funds**
Lockyer Travelling Fellowship
Thomas Watts Eden Fellowship
Other Funds
**Research funds**
Sir William Gilliatt Memorial Fund
Edgar Research-Jean Ethel Gentilli
**Other special purpose funds**
Marjorie Kuck
Millennium Endometriosis Fund
Trusts Capital Fixed Asset Fund
Making Abortion Safe
Lindsay Stewart Centre and related activities
Covid-19 Impact on Inequalities
Brain Injury Reduction
Other funds
**Government grants**
EFL
Obstetric Workforce
Other
**Total restricted funds**|2024
£
667,802
75,104
2,474
745,380
33,157
1,436,521
1,469,678
26,748
40
2,717,371
-
199,385
16,789
92,173
470,708
3,523,214
19,337
8,103
23,381
50,821
5,789,093|Income
£
29,233
-
-
29,233
1,388
66,207
67,595
1,234
2
-
-
-
-
-
837,190
838,426
-
-
64,966
64,966
1,000,220|Expenditure
£
(33,163)
3,341
-
(29,822)
(3,088)
(1,007)
(4,095)
-
-
(198,358)
-
(131,606)
(3,595)
-
(675,374)
(1,008,933)
-
-
(79,919)
(79,919)
(1,122,769)|Gains & Losses
9,732
-
-
9,732
462
22,041
22,503
411
1
-
-
-
-
-
929
1,341
-
-
-
-
33,576|Transfers
£
-
-
(2,849)
(2,849)
-
-
-
-
-
94,978
-
-
-
-
(252,230)
(157,252)
-
-
(8,428)
(8,428)
(168,169)|**2025**
**£**
**673,604**
**78,445**
**(15)**|
|---|---|---|---|---|---|---|
|||||||**752,034**|
|||||||**31,919**
**1,523,762**|
|||||||**1,555,681**|
|||||||**28,393**
**43**
**2,613,991**
**-**
**67,779**
**13,194**
**92,173**
**381,223**|
|||||||**3,196,796**|
|||||||**19,337**
**8,103**
**-**|
|||||||**27,440**|
|||||||**5,531,951**|
57
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
|**24b**
**Movements in funds - restricted funds (prior year)**
**Restricted funds:**
**Scholarship and lecture funds**
Lockyer Travelling Fellowship
Thomas Watts Eden Fellowship
Other Funds
**Research funds**
Sir William Gilliatt Memorial Fund
Edgar Research-Jean Ethel Gentilli
**Other special purpose funds**
Marjorie Kuck
Millennium Endometriosis Fund
Trusts Capital Fixed Asset Fund
Making Abortion Safe
Lindsay Stewart Centre and related activities
Covid-19 Impact on Inequalities
Brain Injury Reduction
Other funds
**Government grants**
EFL
Global Health Partnership
Other
**Total restricted funds**|At 1 January
2024
£
549,256
70,645
1,872
621,773
26,464
1,095,589
1,122,053
20,245
124
2,890,416
210,918
136,345
36,663
115,720
721,165
4,131,596
19,337
92,830
8,428
120,595
5,996,017|Income
£
35,679
8,420
122
44,221
1,719
71,167
72,886
1,315
8
-
-
-
-
-
588,492
589,815
-
-
335,298
335,298
1,042,220|Expenditure
£
(57,890)
(3,961)
-
(61,851)
(1,808)
(1,000)
(2,808)
-
(124)
(200,465)
(242,372)
51,824
(19,874)
(23,547)
(898,730)
(1,333,288)
-
(84,727)
(320,345)
(405,072)
(1,803,019)|Gains &
Losses
140,757
-
480
141,237
6,782
280,765
287,547
5,188
32
-
-
-
-
-
45,719
50,939
-
-
-
-
479,723|Transfers
£
-
-
-
-
-
(10,000)
(10,000)
-
-
27,420
31,454
11,216
-
-
14,062
84,152
-
-
-
-|**At 31 December**
**2024**
**£**
**667,802**
**75,104**
**2,474**|
|---|---|---|---|---|---|---|
|||||||**745,380**|
|||||||**33,157**
**1,436,521**|
|||||||**1,469,678**|
|||||||**26,747**
**40**
**2,717,371**
**-**
**199,385**
**16,789**
**92,173**
**470,708**|
|||||||**3,523,213**|
|||||||**19,337**
**8,103**
**23,381**|
|||||||**50,821**|
||||||74,152|**5,789,093**|
58
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **24 Movements in funds - restricted funds (continued)**
## **Purposes of restricted funds**
## **Scholarship and Lecture Funds**
## **Lockyer Travelling Fellowship**
To fund College travel and facilitate links with Fellows and Members.
## **Thomas Watts Eden Fellowship**
A fund for the provision of travel awards to Fellows and Members.
## **Other Funds**
Comprise small funds for the provision of travel awards to Fellows and Members.
The Charity Commission have approved repurposing £167,602 of this restricted fund, this is now included within the new classification "Repurposed - Restricted". £11,943 as General Lectureship & £155,659 as General Scholarship.
## **Research funds**
## **Sir William Gilliatt Memorial fund**
To encourage research in all aspects of Obstetrics and Gynaecological medicine.
## **Edgar Research – Jean Ethel Gentilli**
To fund education and or research into Obstetrics and or Gynaecology. Transfers out of restricted funds represent the net book value of the assets purchased with these grants being transferred into designated funds.
## **Other Special Purpose Grants**
## **Marjorie Kuck Millennium**
For research into the medical problems of Obstetrics.
## **Millenium Endometriosis fund**
To stimulate and encourage research in the field of endometriosis. Alternatively, to provide a contribution towards a travelling fellowship to attend a recognised training centre.
## **Making Abortion Safe**
Funding for a programme to increase healthcare professionals’ capacity to address the barriers to safe abortion and post-abortion care for women and girls globally.
## **Lindsay Stewart Centre and related activities**
Funding for the Lindsay Stewart Centre for Audit and Clinical Informatics.
## **Covid -19 Impact on Inequalities**
A research programme to assess the impact of COVID-19 on service provision and maternal and neonatal outcomes.
## **Brain Injury Reduction**
59
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
To develop standardised tools and training to reduce the rate of intrapartum brain injuries.
## **Trusts Capital Fixed Asset Fund**
This represents the net book value of tangible fixed assets that are funded from various restricted funds.
## **Other Funds**
Comprise small funds that facilitate travel and international liaison and various small restricted donations and prize funds.
The Charity Commission have approved repurposing £67,630 of this restricted fund, this is now included within the new classification "Repurposed -Restricted". £15,214 as General Lectureship, £10,262 as General Scholarship, £16,099 as General Purpose and £25,786 as Works of Art.
## **Government Grants**
## **International project funds**
This represents funds received from various sources to fund international work including the work of the international liaison group. The balance on this fund has been transferred to other special purpose funds within restricted funds.
## **EFL**
Funds received for the development and delivery of the elearning fetal monitoring programme.
## **Obstetric Workforce**
This represents the second phase of the work funded by the Department of Health and Social Care.
60
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
|**25a**
**Designated Funds**
**Designated funds**
Fixed Asset Fund
Overseas fund
Heritage Fund
John Lawson Fund
Herbert Erik Reiss Memorial Fund
Edgar Gentilli Research Fund
Maternal 3rd World Care
Long term liability Fund
Trainees Committee Fund
Congress Fund
Scottish Executive Committee
**Total designated funds**
**General funds**
**,**
**Total unrestricted funds**
**25b**
**Movements in funds - unrestricted funds (prior period)**
**Designated funds**
Fixed Asset Fund
Overseas fund
Heritage Fund
John Lawson Fund
Herbert Erik Reiss Memorial Fund
Edgar Gentilli Research Fund
Maternal 3rd World Care
Long term liability Fund
Trainees Committee Fund
Scottish Executive Committee
**Total designated funds**
**General funds**
**Total unrestricted funds**|2024
£
39,630,571
9,888
300,000
26,873
12,931
6,827
1,909
1,879,738
24,680
-
104,418
41,997,835
8,621,114
50,618,949
2024
£
40,035,062
9,888
300,000
26,873
12,931
6,827
1,909
901,476
24,680
-
41,319,646
8,238,526
49,558,172|Income & gains
£
-
-
-
-
-
-
-
-
-
-
-
-
20,675,581
20,675,581
Income & gains
£
-
-
-
-
-
-
-
-
-
104,725
104,725
19,818,161
19,922,886|Expenditure & losses
£
(684,387)
-
-
-
-
-
-
-
(4,449)
-
-
(688,836)
(19,320,974)
(20,009,810)|Transfers
£
1,403,079
-
-
-
-
-
-
629,000
-
116,000
41
2,148,120
(2,135,322)
12,798
Transfers
£
514,344
-
-
-
-
-
-
978,262
-
-
1,492,606
(1,549,338)
(56,732)|**2025**
**£**
**40,349,263**
**9,888**
**300,000**
**26,873**
**12,931**
**6,827**
**1,909**
**2,508,738**
**20,231**
**116,000**
**104,459**|
|---|---|---|---|---|---|
||||||**43,457,119**
**7,840,399**|
||||||**51,297,518**|
||||Expenditure & losses
£
(918,835)
-
-
-
-
-
-
-
-
(307)
(919,142)
(17,886,235)
(18,805,377)||**2024**
**£**
**39,630,571**
**9,888**
**300,000**
**26,873**
**12,931**
**6,827**
**1,909**
**1,879,738**
**24,680**
**104,418**|
||||||**41,997,835**
**8,621,114**|
||||||**50,618,949**|
61
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **25 Purposes of designated funds**
## **Fixed Asset fund**
Representing the net book value of all assets in use by the College in furtherance of its charitable activities.
## **Overseas fund**
For the provision of travel for overseas Members of the College to undertake further training in the UK.
## **Heritage fund**
These funds represent those assets donated to the College at their market value.
## **John Lawson fund**
For the award of a Prize awarded to the candidate who provides the best article on a topic of O&G derived from work carried out in Africa.
## **Herbert Erik Reiss Memorial fund**
For the award of a Prize for junior doctors working in Foundation Yrs 1 and 2 or Specialist Training years 1 & 2 in the UK and ROI.
## **Edgar Gentilli Research fund**
To generate income to fund an annual Prize in perpetuity.
## **Maternal 3rd World Care**
To subsidise the production costs of a RCOG Press book called “Maternity Services in the Developing World.”
## **Long term liability fund**
Funds designated by the Board to manage future pension and estate planning.
## **Trainees’ Committee fund**
Funds designated by the Board for use by the Trainees’ Committee.
## **Scottish Executive Committee fund**
The Scottish Fund Committee is set up to progress the charitable activity of the college in Scotland.
## **26 Operating lease commitments receivable as a lessor**
Amounts receivable by the group under non-cancellable operating leases are as follows for each of the following periods:
|Less than 1 year
1 - 5 Years|Property
**2025**
December
2024
**£**
£
**279,744**
251,127
**786,055**
291,960
**1,065,799**
543,087|Property
**2025**
December
2024
**£**
£
**279,744**
251,127
**786,055**
291,960
**1,065,799**
543,087|
|---|---|---|
|||543,087|
62
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **27[Pension Costs ]**
## _Defined Contribution Scheme_
The College operates a pension scheme based on defined contributions. The assets of the scheme are held separate from those of the College and are invested in exempt approved investment funds. The defined contribution scheme is open to all staff. The cost for the period was £884,276.06 (2024: £865,371).
## _Defined Benefit Scheme_
The College sponsors the Royal College of Obstetricians and Gynaecologists Pension Scheme which is a funded defined benefit arrangement. This is a separate trustee administered fund holding the pension scheme assets to meet long term pension liabilities for some 115 past and around 8 present employees. The level of retirement benefit is principally based on the best salary earned in the last three years of employment.
The Trustees of the scheme are required to act in the best interest of the scheme's beneficiaries. During 2016 the Scheme moved to a sole trustee structure.
A full actuarial valuation of the scheme was carried out as at 01 April 2024 in accordance with the scheme funding requirements of the Pensions Act 2004 and the funding of the scheme is agreed between the College and the Trustees in line with these requirements. These, in particular, require the deficit to be calculated using prudent, as opposed to best estimate, actuarial assumptions. The actuarial valuation showed a funding shortfall of £2m.
The Scheme is a non-segregated multi-employer scheme. On an approximate basis, RCOG is responsible for circa 87% of the total liability.
For the purposes of FRS102, the preliminary actuarial valuation as at 1 April 2019, which was carried out by a qualified independent actuary, has been updated on an approximate basis to 31 December 2024. This update is inherently less rigorous than a full valuation, adding to the level of uncertainty which pervades any assessment of the current value of the scheme's long-term obligations and likely ability of the expected performance of its assets to meet those obligations.
Present values of RCOG's share of scheme liabilities, fair value of assets and deficit
|Fair value of scheme assets
Present value of scheme liabilities
Surplus in scheme
Asset ceiling adjustment
Total|**2025**
**£'000**
**13,738**
**(13,607)**
**131**
**(131)**
**-**|**2024**
£'000
14,429
(13,676)|
|---|---|---|
|||573|
|||(573)|
|||-|
The present value of scheme is measured by discounting the best estimate of future cash flows to be paid out by the scheme using the projected unit method. The value calculated in this way is reflected as nil in the balance sheet as RCOG are not able to recoup the value of this asset.
63
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
Reconciliation of opening and closing balances of the present value of the scheme liabilities:
|Scheme liabilities at start of period
Interest cost
Actuarial (gains)/ losses
Benefits paid and expenses
Scheme liabilities at end of period|**2025**
**£000**
**13,676**
**732**
**(41)**
**(760)**
**13,607**|2024
£000
15,378
673
(1,523)
(852)|
|---|---|---|
|||13,676|
Reconciliation of opening and closing balances of the present value of the scheme assets:
|Fair value of scheme assets at period start
Expected return on scheme assets
Contributions by employer
Administrative expense
Interest income
Benefits paid and expenses
Fair value of scheme assets at end of period|**2025**
**£'000**
**14,249**
**(275)**
**16**
**(249)**
**757**
**(760)**
**13,738**|2024
£'000
**16,283**
**(1,587)**
**200**
**(502)**
**707**
**(852)**|
|---|---|---|
|||14,249|
The actual gain on the scheme assets over the period ending 31 December 2025 was £482,000 (2024: loss of £880,000).
## **Contributions**
The best estimate of contributions to be paid by the employer to the scheme for the period beginning after 31 December 2023 is £565,445 (2022: £284,625).
|Administration expenses
Interest on obligations|**2025**
**£'000**
**249**
**-**
**249**|2024
£'000
502
-|
|---|---|---|
|||502|
64
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
Reconciliation of opening and closing balances of the present value of the scheme liabilities:
|**2025**
**£000**
Difference between expected and actual return on scheme assets
Amount: (loss)/gain
**(275)**
Experience: gains and lossess arising on the scheme liabilities
Amount: gain
**41**
Amount: gain
**(234)**
The major categories of plain assets as a percentage of total plan assets are as follows:
**2025**
Equities & Diversified Growth Funds
**0.0%**
Cash & other
**35.8%**
Liability Driven Investments
**64.2%**
Total assets
**100.0%**|2024
£000
(1,587)
1,523
(64)|
|---|---|
||2024
0.0%
67%
33%|
||100.0%|
## **Assumptions**
||||30 June|30 June|30 June|
|---|---|---|---|---|---|
||2025|2024|2022|2022|2021|
||%|%|%|%|%|
|Inflation – CPI|2.5|2.8|2.7|2.4|2.4|
|Salaryincreases|2.9|3.0|3.0|3.0|3|
|Rate of discount|5.6|5.5|4.5|3.8|1.8|
|Allowance for pension in payment increases of RPI or
5%p.a. if less|2.9|3.0|2.9|3.1|3.2|
|Allowance for revaluation of deferred pensions of RPI or
5%p.a. if less|2..5|2.8|2.7|2.4|2.4|
The morality assumptions adopted are based on those applied in the most recent formal actuarial valuation as at 1 April 2022 updated to 31 December 2024 by a qualified actuary:
|Male aged 60 at period end
Female ages 60 at period end
Male at age 60, aged 40 at period end
Female at age 60, aged 40 at period end
Scheme liabilities at end of period|**2025**
**26.3 years**
**28.9 years**
**27.9 years**
**30.4years**
**(234)**|2024
26.0 years
28.8 years
27.6 years
30.3years
(64)|
|---|---|---|
65
**Royal College of Obstetricians and Gynaecologists**
## **Notes to the financial statements**
## **For the year ended 31 December 2025**
## **Amounts for the current and previous periods**
||**2025**|2024|
|---|---|---|
||**£’000**|£’000|
|Fair value of assets|**13,738**|14,249|
|Present value of scheme liabilities|**13,607**|(13,676)|
|Surplus/(deficit)|**131**|573|
|Experience adjustment on scheme assets|**41**|1,523|
|Effects of changes in the demographic and financial assumptions underlying the
present value of the scheme liabilities|||
||**(275)**|(1,587)|
## **28 Contingent Liability**
One of the leases signed by one of its tenants allows for a potential reimbursement of costs incurred by the tenant if certain conditions are met after 10 years and 15 years. The maximum potential liability amounts to £130,000. At 31 December 2024, it is not anticipated that these conditions will be met and no provision is therefore included in the accounts.
## **29 Capital Commitment**
|Contracted for but not provided in the financial statements
**Total**|**2025**
**£**
**253,287**
**253,287**|2024
£
-|
|---|---|---|
|||-|
At 31 December 2025, the charity had capital commitments contracted for £253,287 (2024: nil) relating to property works.
66